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ABSTRACT

Liao, Pin-Chao. Ph.D., Purdue University, December 2016. ROS Regulation of Axonal
Mitochondrial Transport. Major Professor: Peter J. Hollenbeck.

Mitochondria perform critical functions including aerobic ATP production and calcium
(Ca2+) homeostasis, but are also a major source of reactive oxygen species (ROS)
production. To maintain cellular function and survival in neurons, mitochondria are
transported along axons, and accumulate in regions with high demand for their functions.
Oxidative stress and abnormal mitochondrial axonal transport are associated with
neurodegenerative disorders. However, we know little about the connection between
these two. Using primary Drosophila neuronal cell culture and the third instar larval
nervous system as in vitro and in vivo models, respectively, we studied mitochondrial
transport under oxidative stress conditions. In vitro, hydrogen peroxide (H2O2)
diminished the percentage of moving mitochondria, the mitochondrial length and inner
membrane potential. In vivo, ROS inhibited specifically mitochondrial axonal transport,
primarily due to reduced flux and velocity, but did not affect transport of other organelles.
In addition to excess ROS, down-regulation of Nox or Duox expression, which reduces
endogenous ROS levels, mitochondrial transport was impaired. To understand the
mechanisms underlying these effects, we examined Ca2+ levels and the JNK (c-Jun Nterminal Kinase) pathway, which have been shown to regulate mitochondrial transport
and general fast axonal transport, respectively. We found that elevated ROS increased
Ca2+ levels, and that the Ca2+ chelator EGTA rescued ROS-induced defects in
mitochondrial transport. In addition, activation of the JNK pathway reduced
mitochondrial flux and velocities, while JNK knockdown partially rescued ROS-induced
defects in the anterograde direction. We conclude that ROS have the capacity to regulate

xvi
mitochondrial traffic, and that Ca2+ and JNK signaling play roles in mediating these
effects.
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CHAPTER 1. INTRODUCTION

1.1

1.1.1

Mitochondrial transport in neurons

Importance of mitochondrial transport in neurons

Neurons have an exceptional cellular morphology because of their asymmetry and long
length.

This

somato-dendritic,

axonal,

and

synaptic

terminal

regions

have

compartmentalized differences in molecular machinery and signaling. The cell body is
the crucial region for synthesis and degradation of proteins or organelles, but axonal
regions also have low levels of protein synthesis. Thus, it is a thought that after protein
synthesis in the soma, cargoes are transported from the soma to the synaptic terminals
(anterograde transport), and accumulate in regions with high demand for their functions.
When materials are aged, they could be transported back to the cell body for recycling or
degradation (retrograde transport) (Saxton and Hollenbeck, 2012) (Fig. 1.1A).
Among all neuronal cargoes, mitochondria are one of the important organelles.
Mitochondria are the source of aerobic ATP production for the cell and also contribute to
calcium (Ca2+) homeostasis. Neurons need large amounts of ATP to maintain their high
metabolism. Among the different regions of neurons, synapses have among the highest
demand for mitochondrial ATP. When a synaptic vesicle releases neurotransmitter,
hundreds of postsynaptic channel open and lots of ions enter the cell. To maintain the ion
gradients, ATP is required for pumping them back across the plasma membrane (Schwarz,
2013). In addition to the synapse, action potentials also require energy to maintain ion
gradients. Two groups have provided evidence that in myelinated nerves, increased
electric activity decreases mitochondrial transport in the node of Ranvier or paranodal
region. Without stimuli, most stationary mitochondria localize in the internodal or
juxtparanodal region (Zhang et al., 2010; Ohno et al., 2011). The high demand for ATP
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and other mitochondrial functions such as Ca2+ buffering in this region of the nerve is
presented to underlie this localization, and I conclude that correct distribution and
transport of mitochondria is crucial for nerves.

1.1.2

Behaviors of mitochondrial transport

Different axonal organelles or cargoes have their preferred dominant direction of
transport. For example, fast-moving axonal vesicles containing neuropeptides
preferentially move anterogradely (Barkus et al., 2008). On the other hand, the dominant
direction of autophagosomes and organelles carrying endocytic cargoes is retrograde
(Hollenbeck, 1993; Maday et al., 2012).
Axonal mitochondria exhibit unique transport behaviors, with about 70% of them
being stationary and 30% motile (Morris and Hollenbeck, 1993; Pilling et al., 2006;
Devireddy et al., 2015). In the motile population, about 2/3 move anterogradely and 1/3
move retrogradely. In the long distance movement, mitochondria usually move with
continuous runs intermixed with short pauses or oscillations. They sometimes change
direction for a short period but retrun to movement in their primary direction; completely
reversed directions are rare (Morris and Hollenbeck, 1993; Pilling et al., 2006; Devireddy
et al., 2015). These unique transport behaviors are regulated by motor proteins, adaptor
proteins, and anchor proteins, which are described in the following sections.

1.1.3

Key proteins for mitochondrial transport

1.1.3.1 Microtubule-based motor proteins – kinesin and dynein
The best-known motor proteins for long distance movement of mitochondria are the
microtubule-based motor proteins, kinesin and dynein. Kinesin is responsible for
anterograde transport, and dynein is responsible for retrograde transport (Pilling et al.,
2006; Saxton and Hollenbeck, 2012) (Fig. 1.1B, E).
Then main kinesin family that plays a key role in mitochondrial anterograde transport
is the kinesin-1 family (also known as KIF5). In mammals, there are three isoforms of
KIF5: KIF5A, KIF5B, and KIF5C. All of them have two kinesin heavy chains (KHCs)
that dimerize by coiled-coil interactions and two kinesin light chains (KLCs). Each KHC
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has a motor domain in the amino-terminal that binds to microtubules and moves toward
the microtubule plus ends; in the carboxy-terminal, it contains a cargo-binding domain
that is associated with KLCs to bind cargoes or adaptor proteins (Hirokawa et al., 2010).
In mitochondrial axonal transport, mutations of khc (Drosophila KIF5 homologue)
produce impaired mitochondrial transport (Pilling et al., 2006). This indicates that
kinesin-1 is the primary mitochondrial motor for the anterograde direction. In addition to
kinesin-1, KIF1B, one of the kinesin-3 family proteins, has been suggested to transport
mitochondria based on an in vitro study (Nangaku et al., 1994). KLP6, a newly identified
kinesin, may also regulate mitochondrial transport in neuronal cells (Tanaka et al., 2011).
Cytoplasmic dynein contains two dynein heavy chains (DHCs), several light chains
(DLCs), light intermediate chains (DLICs), and intermediate chains (DICs). DHCs serve
as motors in dynein. Other structures can interact with dynactin, a large complex
regulating the interaction between cargoes, microtubules, and dynein, to transport cargoes
(Hirokawa et al., 2010). In Drosophila, mutations of the dynein heavy chain (Dhc)
produce reduced velocity and run length of retrograde mitochondrial transport (Pilling et
al., 2006). Down-regulation of the dynactin subunit p150Glued also reduces mitochondrial
transport (Pilling et al., 2006). These studies indicate that dynein is the primary motor for
mitochondrial retrograde transport.
While kinesin and dynein have their dominant directions of movement, their actions
can be interdependent. From genetic analysis in Drosophila, mutations of kinesin-1
exhibit genetic interactions with mutations of dynein and dynactin (Martin et al., 1999).
Mutations of dynein inhibit retrograde mitochondrial transport, whereas mutations of
kinesin-1 inhibit mitochondrial transport in both directions (Pilling et al., 2006),
indicating there are some interactions between kinesin and dynein. Although Miro
possibly interact with both kinesin and dynein (Russo et al., 2009) (More detailed in
Section 1.1.3.4), how these proteins cooperate to control mitochondrial transport remains
unclear.
1.1.3.2 Actin-based motor protein – myosin
Since axons contain actin filaments with mixed polarity, and mitochondria have been
shown to transport on both microtubules and actin filaments (Morris and Hollenbeck,

4
1995; Bridgman, 2004; Saxton and Hollenbeck, 2012), raising the issue of a role for
myosin in mitochondrial transport. In vertebrate neuronal cultures, disruption of actin
filaments increases the velocity of mitochondrial transport (Morris and Hollenbeck,
1995). In Drosophila neuronal cell culture, down-regulation of myosin V increases
mitochondrial transport in both directions. Moreover, down-regulation of myosin VI also
increases mitochondrial transport but only in the retrograde direction (Pathak et al., 2010).
These suggest that myosin competes with microtubule-based motors and thereby supports
mitochondria halting along the axon (Fig. 1.1D).
1.1.3.3 Microtubule-based docking protein -- syntaphilin
Recently, Sheng’s group identified a new protein, syntaphilin, that can anchor
mitochondria on microtubules (Kang et al., 2008; Chen et al., 2009; Chen and Sheng,
2013) (Fig.1.1C). Syntaphilin was originally reported to regulate fusion or docking of
synaptic vesicles by inhibiting SNARE (Soluble NSF Attachment Protein Receptor)
formation (Lao et al., 2000). In its carboxyl-terminal domain, syntaphilin has the
structure that target to mitochondrial outer membrane. It also contains the microtubule
binding domain (Kang et al., 2008). In the stationary mitochondria population, most of
mitochondria are co-localized with syntaphilin, whereas moving mitochondria are not.
Syntaphilin-tagged mitochondria are highly correlated to the stationary mitochondria.
When the syntaphilin gene (snph) is deleted, mitochondrial transport dramatically
increases; overexpression of syntaphilin produces an almost immobilized population of
mitochondria (Kang et al., 2008). Ca2+ can regulate the effects of syntaphilin on
mitochondrial docking (Chen and Sheng, 2013). Interestingly, dynein light chain LC8 is
shown to associate with syntaphilin, facilitating interactions between syntaphilin and
microtubules (Chen et al., 2009). However, syntaphilin only exists in mammals and is
not found, for example, in Drosophilia genome. Yet Drosophila also shows a similar
stationary population of mitochondria, suggesting that other mitochondrial-docking
machineries may play an important role in stopping mitochondrial movement. Thus, the
mitochondrial docking proteins and mechanisms require further investigation.
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1.1.3.4 Motor adaptor proteins – Miro and Milton
Miro and Milton are two important adaptor proteins connecting mitochondria to the
kinesin-1 motor for transport (Fig. 1.1 and 1.2A). Miro, a mitochondrial outer membrane
Rho GTPase protein, was found and characterized in both humans and Drosophila
(Fransson et al., 2003; Guo et al., 2005). Miro has two EF-hand Ca2+-binding motifs and
GTPase domains. In a Drosophila genetic screen, mutations of Drosophila Miro impaired
mitochondrial axonal transport to the synapses (Guo et al., 2005). Similarly, human Miro1 and Miro-2 are both essential for mitochondrial traffic in mammals (Fransson et al.,
2003; Fransson et al., 2006). Interestingly, mutations in Miro produce a reduction of
mitochondrial transport both anterogradely and retrogradely, suggesting a possible
interaction between Miro and both kinesin and dynein (Russo et al., 2009). This has not
been explored.
Milton is a linker protein between mitochondria and kinesin, first identified from a
Drosophila genetic screen (Stowers et al., 2002). In homozygous Milton mutants,
mitochondria are rare in the terminals of photoreceptors, but are still present in the soma
of these cells (Stowers et al., 2002; Górska-Andrzejak et al., 2003). This study suggests
that Milton is involved in the mediation of mitochondrial transport. In addition, Milton
has been shown to bind directly to the carboxyl-terminal region of KHCs and interacts
with Miro, providing the evidence that Miro, Milton, and KHC form an essential protein
complex for mitochondrial anterograde transport (Glater et al., 2006).
In mammals, two Milton orthologues TRAK1 and TRAK2 (also known as OIP106 and
Grif1, respectively) have been identified and been shown as adaptor proteins physically
binding to kinesin motors (Brickley et al., 2005; Smith et al., 2006). Evidence that
mammalian TRAK family are involved in the regulation of mitochondrial transport are
also provided. Elevated Miro 1 levels recruit TRAK2 to mitochondria and increase
mitochondrial transport to the distal ends of neuronal process in hippocampal neurons
(MacAskill et al., 2009). In addition, down-regulation of TRAK1 impair mitochondrial
transport in axons (Brickley and Stephenson, 2011).
An overall picture of current model of the mitochondrial transport machinery is shown
in figure 1.1B – E: For anterograde transport of mitochondria, mitochondria connect to
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kinesin-1 using adaptor proteins Miro, Milton, or others (Fig. 1.1E). For retrograde
transport, dynein is the primary motor (Fig. 1.1B). For stationary mitochondria, myosin
may compete with kinesin or dynein to halt mitochondria (Fig. 1.1D). Syntaphilin is
another docking protein in mammals (Fig. 1.1C). Other unknown regulating proteins or
factors are also involved in this transport machinery.

1.1.4

Regulation of mitochondrial transport

1.1.4.1 Cytosolic Ca2+ in the regulation of mitochondrial transport
Ca2+ is one of the most-studied factors regulating mitochondrial transport. In cardiac
myoblasts, elevated Ca2+ levels in the physiological range inhibit mitochondrial
movement (Yi et al., 2004). In primary neuronal culture, synaptic activity or activation of
the glutamate receptors increases Ca2+ and reduces mitochondrial transport (Rintoul et al.,
2003; Chang et al., 2006a). Furthermore, in myelinated nerves, increased Ca2+ levels
caused by action potentials also reduce mitochondrial motility (Zhang et al., 2010; Ohno
et al., 2011). These raise the question: what are the regulators and mechanisms for
mitochondrial transport in response to Ca2+? To date, there are three groups proposing
different models of the mechanisms by which mitochondrial halting occurs. (Macaskill et
al., 2009; Wang and Schwarz, 2009; Chen and Sheng, 2013) (Fig. 1.2).
MacAskill et. al suggest that Miro is the Ca2+ sensor for mitochondrial transport and
physically interacts with kinesin. When Ca2+ levels increase, Ca2+ binds to the EF motifs
on Miro, and that releases the mitochondria-Miro-TRAK complex from kinesin. As a
result, mitochondrial transport is inhibited (Macaskill et al., 2009) (Fig. 1.2A, B). Wang
and Schwarz propose a similar mechanism. Miro physically binds to kinesin, and
elevated Ca2+ levels inhibit mitochondrial transport. However, when Ca2+ levels increase,
kinesin remains attached to the mitochondria-Miro-TRAK complex. Ca2+ binds to the EFdomain of Miro and induces the attachment of the kinesin motor domain to Miro instead
of microtubules, slacking the interaction between kinesin and microtubules (Wang and
Schwarz, 2009) (Fig. 1.2C). A recent study from Chen and Sheng included another
proposed model of mitochondrial transport inhibition. They suggest that elevated Ca2+
levels immobilize mitochondrial transport via docking protein, syntaphilin. They propose
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that syntaphilin competes with TRAK and inhibits kinesin motor ATPase activity, such
that kinesin cannot move along microtubules. When Ca2+ levels increase, it favors the
interaction between syntaphilin and kinesin instead of TRAK and kinesin. Thus,
mitochondrial movement stops (Chen and Sheng, 2013) (Fig. 1.2D). Overall, although
they propose different models, all groups indicate that Ca2+ binding to the EF-domain of
Miro inhibits mitochondrial transport.
1.1.4.2 Signaling pathways in the regulation of mitochondrial transport
Although Ca2+ is the most-studied regulator for mitochondrial transport, many
signaling pathways have been shown to play roles in the regulation of general or
mitochondrial transport in neurons. In axons, mitochondria are recruited in response to
Nerve Growth Factor (NGF), and this recruitment is inhibited by the phosphoinositide 3kinase (PI3K) inhibitors, suggesting that the PI3K signaling pathway play a role in the
regulation. (Chada and Hollenbeck, 2003, 2004).
In addition, Akt/Gsk3β signaling has been shown to mediate general or mitochondrial
axonal transport. Glycogen synthase kinase 3 (Gsk3) can phosphorylate kinesin light
chain, which reduces the binding affinity between kinesin-1 and its cargoes, thereby
inhibiting axonal organelle transport (Morfini et al., 2002). Other studies show that
Gsk3β can regulate mitochondrial transport, but the results are controversial. Inhibition of
Gsk3β, whose activity is blocked by Akt-mediated phosphorylation, stimulates axonal
mitochondrial transport (Chen et al., 2007). However, other studies show that
overexpression of Gsk3β increases mitochondrial transport in both directions, but more
robustly in the anterograde direction (Llorens-Martín et al., 2011; Ogawa et al., 2016).
This regulation possibly depends on the microtubule associated proteins, Tau, that can be
phosphorylated by GSK3 and regulate the bindings of motors to microtubules (LlorensMartín et al., 2011), or association with TRAK (Ogawa et al., 2016).
Another possible component is the C-Jun N-terminal Kinase (JNK) signaling pathway.
Activation of JNK can phosphorylate kinesin heavy chain and reduce its interaction
between kinesin and microtubules, thereby causing inhibition of axonal transport
(Morfini et al., 2006; Morfini et al., 2009).
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1.1.4.3 PINK1/Parkin in the regulation of mitochondrial transport
PINK1 and Parkin are two critical genes for a familial early-onset form of Parkinson’s
disease (Kitada et al., 1998; Valente et al., 2004). PINK1 is PTEN-induced putative
kinase 1 and Parkin is an E3 ubiquitin ligase. Both of them are important for
mitochondrial function and in the same signaling pathway where Parkin is downstream of
PINK1 (Greene et al., 2003; Clark et al., 2006; Park et al., 2006). In healthy mitochondria,
PINK1 is imported through the translocases TIM (Translocase complex of inner
membrane) and TOM (Translocase complex of outer membrane) and cleaved by
mitochondrial-processing protease (MPP) and presenilin-associated rhomboid-like
protease (PARL) (Meissner et al., 2011; Greene et al., 2012). However, when
mitochondria are depolarized, PINK1 is stabilized on mitochondrial outer membrane,
where it recruits Parkin and induces mitophagy (Narendra et al., 2008; Matsuda et al.,
2010; Narendra et al., 2010; Lazarou et al., 2012).
The first evidence relating PINK1/Parkin to mitochondrial transport is that PINK1
forms a complex with Miro and Milton (Weihofen et al., 2009). Later, Wang et. al
provided the evidence that PINK1 and Parkin are involved in the regulation of
mitochondrial transport by inhibiting mitochondrial movement (Wang et al., 2011) (Fig.
1.3). They showed that overexpression of PINK1 or Parkin inhibits mitochondrial
movement in mammalian hippocampal and Drosophila CCAP neurons. In addition,
knockdown of PINK1 or Parkin increases mitochondrial movement in Drosophila,
suggesting that PINK1 and Parkin play a role in the regulation of mitochondrial transport.
To induce the PINK1/Parkin pathway, cells are treated with carbonyl cyanide mchlorophenylhydrazone (CCCP). Under these conditions, PINK1 and Parkin are
associated with Miro. In addition, PINK1 phosphorylates Miro, which induces
degradation of Miro and results in the release of kinesin and Milton from mitochondria
(Wang et al., 2011). Another group provide the evidence that Miro is the substrate of
Parkin (Liu et al., 2012). Based on these results, Wang et al. proposes this model. When
mitochondria are depolarized, they recruit PINK1, which phosphorylates Miro (Fig.
1.3B). This PINK1-phosphorylated Miro may recruit Parkin, which induces Miro
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ubiquitination (Fig. 1.3C). Ubiquitinated Miro is then degraded, so mitochondria release
from microtubules and stop (Fig. 1.3D).
Although they proposed this model, a recent study shows the opposite results.
Devireddy et al. examined mitochondrial transport, morphology, and membrane potential
in PINK1 mutation in the Drosophila motor neurons. They shows that PINK1 nullmutation inhibits mitochondrial transport by reducing flux in both directions and
anterograde duty cycle, whereas overexpression of PINK1 increases retrograde moving
mitochondria (Devireddy et al., 2015). Thus, it still remains unclear how PINK1/Parkin
regulate mitochondrial transport.
1.1.4.4 Interrelationship of mitochondrial metabolic state, fission-fusion dynamics, and
transport
Since motor proteins require ATP for their activity, mitochondrial metabolic state
might be associated with mitochondrial transport. In mammalian primary neurons, cells
treated by ATPase blocker oligomycin or by an uncoupler (FCCP or CCCP), which
inhibits mitochondrial electron transport, show a decrease in mitochondrial transport
(Rintoul et al., 2003; Miller and Sheetz, 2004). However, treatment with antimycin, an
inhibitor of mitochondrial complex III, increases mitochondrial transport (Miller and
Sheetz, 2004). These results suggest that there might be some connections between
mitochondrial metabolic state and transport. However, it remains controversial whether
mitochondrial membrane potential is different between axonal mitochondria moving in
different directions (Miller and Sheetz, 2004; Verburg and Hollenbeck, 2008). Miller
and Sheetz suggest that mitochondria with high membrane potential preferentially move
anterogradely, and mitochondria with low membrane potential move retrogradely (Miller
and Sheetz, 2004). Whereas Verburg and Hollenbeck provide the evidence that
anterograde, retrograde, and stationary mitochondria shows no different in mitochondrial
membrane potential (Verburg and Hollenbeck, 2008).
In addition to metabolic state, numerous studies provide evidence that mitochondrial
fission-fusion dynamics are highly interrelated with mitochondrial transport (Rintoul et
al., 2003; Verstreken et al., 2005; Fransson et al., 2006; Baloh et al., 2007; Saotome et al.,
2008; Misko et al., 2010; Pathak et al., 2010; Yu et al., 2016). Primary forebrain neurons
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treated with glutamate show both reduced mitochondrial movement and mitochondrial
length (Rintoul et al., 2003). Overexpression of motor adaptor protein Miro induces
mitochondrial fusion (Fransson et al., 2006; Saotome et al., 2008). Knockdown of
Myosin V, the motor protein for halting mitochondrial transport, increases mitochondrial
length (Pathak et al., 2010)
This connection between fission-fusion and transport might involve mitochondrial
fission or fusion proteins, including Drp1 (Dynamin related protein 1), mitofusin 2, or
Opa1 (Optic atrophy protein 1) (Verstreken et al., 2005; Baloh et al., 2007; Misko et al.,
2010; Yu et al., 2016). In a forward screen in Drosophila, mutations of Drp1, one of the
mitochondrial fission protein, were found to reduce the number of mitochondria in
synaptic terminals (Verstreken et al., 2005). Mitofusin 2, a mitochondrial outer
membrane fusion protein, also interacts with Miro/Milton complex and is required for
mitochondrial transport (Baloh et al., 2007; Misko et al., 2010). Knockdown of
Drosophila Opa1, a mitochondrial inner membrane fusion protein, recently has been
shown to reduce mitochondrial transport in the third instar larval neurons (Yu et al.,
2016), whereas Opa1 has no effect in dorsal root ganglion (DRG) cultures (Misko et al.,
2010).
Overall, although the detailed mechanisms remain unclear, these studies indicate that
mitochondrial metabolic state, fission-fusion dynamics, and transport are highly
interrelated.

1.1.5

Mitochondrial transport and neurodegenerative diseases

Since mitochondrial transport is important for neuronal survival, it is not surprising
that defects in mitochondrial transport are associated with a variety of neurodegenerative
diseases.
Alzheimer’s disease is involved in progressive dementia. Two pathological hallmarks
in Alzheimer’s disease are neuritic plaques containing Amyloid-β aggregates and
neurofibrillary tangles containing hyperphosphorylated Tau proteins. It has been shown
that a short period of exposure of cultured hippocampal neurons to Amyloid-β impairs
mitochondrial transport (Rui et al., 2006). Moreover, this Amyloid-β induced defects of
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mitochondrial transport can be rescued by the reduction of another key pathogenic factor,
Tau (Vossel et al., 2010). In addition to Alzheimer’s disease, recent studies also provided
evidence that factors inducing Parkinson’s disease are associated with impaired
mitochondrial transport (Kim-Han et al., 2011; Devireddy et al., 2015). Environmental
toxin

inducing

Parkinson’s

disease,

1-methyl-4-phenylpyridinium

ion

(MPP+),

specifically induces defects of mitochondrial transport in dopamine axons (Kim-Han et
al., 2011). Mutant PINK1, one of the pathogenic factor inducing familial early-onset
Parkinson’s disease, also impairs mitochondrial transport by reducing flux and duty cycle
(Devireddy et al., 2015).
Other neurodegenerative diseases are also associated with impaired mitochondrial
transport. For example, mutations of superoxide dismutase 1 (SOD1) that induce
amyotrophic lateral sclerosis (ALS) also produce a decrease in mitochondrial transport
(De Vos et al., 2007; Magrané et al., 2009; Magrané et al., 2012; Song et al., 2012).
Mutations of huntingtin, which is associated to Huntington’s disease, can induce defects
in mitochondrial transport, and evidence suggests that this is possibly caused by the
interaction between the amino-terminal of mutant huntingtin and mitochondria (Chang et
al., 2006b; Orr et al., 2008). In addition, pathogenic huntingtin inhibits axonal transport
by the activation of JNK3 and resulting phosphorylation of kinesin (Morfini et al., 2009).
Thus, these studies provide strong evidence that impaired mitochondrial transport is one
of the important factors inducing neurodegenerative diseases.
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Figure 1.1. Mitochondrial transport in axons. A, The simplified representation of a
neuronal cell contains a cell body, dendrites, an axon, and a synaptic terminal.
Mitochondria transport from the cell body to the synaptic terminal (anterograde transport)
or from the terminal to cell body (retrograde transport). Some mitochondria stay
stationary. B – E, Representations of anterograde, retrograde, and stationary
mitochondria. Dynein and kinesin are the primary motors for retrograde and anterograde
transport of mitochondria, respectively (B, E). These motors need adaptor proteins to
bind mitochondria. Syntaphilin is the docking protein for stationary mitochondria in
mammalian neurons (C). Myosin can compete microtubule-based motors (kinesin or
dynein) to halt mitochondria (D).
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Figure 1.2. Models of Ca2+ regulation in mitochondrial transport. A, Miro is the
mitochondrial outer membrane protein and has two Ca2+ binding EF-hand motifs. In the
anterograde moving mitochondria, Miro and the adaptor protein Milton form the complex.
This Miro-Milton complex interacts with kinesin and drives mitochondrial transport
anterogradely. B, In the first model, Ca2+ binds to Miro and that releases kinesin from
mitochondria when Ca2+ levels increase. Thus, mitochondrial transport is reduced
(Macaskill et al., 2009). C, In the second model, Ca2+ binding releases the kinesin motor
domain from microtubules and induces bindings between the motor domain and Miro
(Wang and Schwarz, 2009). D, Syntaphilin is involved in the Ca2+ regulation of
mitochondrial transport. Elevated Ca2+ levels switch kinesin binding from Miro-Milton
complex to the docking protein, synatphilin. Syntaphilin can inhibit the activity of kinesin
motor ATPase, thereby stopping mitochondrial transport (Chen and Sheng, 2013).
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Figure 1.3. Recent model of PINK1/Parkin regulation in mitochondrial transport. A,
Healthy mitochondria move anterogradely via Miro-Milton-kinesin machinery. B,
Unhealthy or depolarized mitochondria recruit PINK1, which phosphorylates Miro. C,
PINK1-phosphorylated Miro may recruit Parkin, which induces Miro ubiquitination. D,
Miro is degraded, so mitochondria release from microtubules and stop.
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1.2

1.2.1

Reactive oxygen species (ROS)

Reactive oxygen species (ROS) and antioxidants

Reactive oxygen species (ROS) are the partially reduced forms of oxygen, which are
highly reactive due to their unstable free radicals. There are several varieties of ROS.
When oxygen is one-electron reduced, it converts to the superoxide anion (O2-·). Twoelectron reduction leads to hydrogen peroxide (H2O2) formation. A further one-electron
reduction of hydrogen peroxide forms the highly reactive hydroxyl radical (OH·)
(Brookes et al., 2004; Son et al., 2013; Lambeth and Neish, 2014) (Fig. 1.4). These ROS
are harmful for cells because they damage macromolecules or subcellular structures such
as proteins, lipids, and DNA (Brookes et al., 2004; D'Autréaux and Toledano, 2007; Son
et al., 2013). Although these ROS are highly reactive and potentially destructive, cells
use their antioxidant systems to control their levels and maintain the ROS balance.
These antioxidant systems include several antioxidant enzymes as well as nonenzymatic antioxidants (Fig. 1.4). Among antioxidant enzymes, superoxide dismutase
(SOD) converts superoxide to hydrogen peroxide. There are three different isoforms of
SOD: SOD1, copper-zinc superoxide dismutase (Cu/Zn SOD), is expressed mostly in the
cytosol. SOD2, manganese superoxide dismutase (Mn SOD), is expressed primarily in
mitochondria. SOD3, extracellular superoxide dismutase (EC SOD), is secreted into the
extracellular space (Mruk et al., 2002). Catalase or glutathione peroxidase (GSH Px)
reduces hydrogen peroxide to water (H2O). Catalase mostly resides in peroxisomes, but
also exists in the cytoplasm and in mitochondria. Glutathione peroxidase reduces
hydrogen peroxide to water using reduced glutathione (GSH) as an electron donor, and
these glutathione then forms disulfide bonds (Gandhi and Abramov, 2012). In addition to
antioxidant enzymes, there are several non-enzymatic antioxidants, including glutathione,
vitamin C and E, thioredoxin (Trx), and others (Gandhi and Abramov, 2012; Son et al.,
2013). These non-enzymatic antioxidants also play important roles in the regulation of
redox balance.
If the balance of ROS and antioxidants is disrupted, excess ROS production can induce
oxidative stress in cells. Oxidative stress has been shown to associate highly with

16
different neurodegenerative diseases and to activate a variety of signaling pathways
(Shen and Liu, 2006; Court and Coleman, 2012; Federico et al., 2012; Fischer et al., 2012;
Son et al., 2013; Bhat et al., 2015), as described below.

1.2.2

Major sources of ROS

1.2.2.1 Mitochondria
Mitochondria are one of the major sources of ROS in the cell. In the mitochondrial
inner membrane, the electron transport chain is one of the important functional parts of
ATP generation, but also is the location of ROS production. ROS are generated in
different sites in the electron transport chain, primarily at complex I (NADH-ubiquinone
oxidoreductase) and III (ubiquinone-cytochrome c reductase) (Brookes et al., 2004; Bhat
et al., 2015; Genova and Lenaz, 2015).
Complex I generates ROS via its iron-sulfur clusters (Genova et al., 2001). These ROS
are produced during forward electron transfer in the electron transport chain and stay in
the matrix. (Genova et al., 2001; Genova and Lenaz, 2015). ROS formation from
complex III depends on the Q-cycle in electron transfer. In the Q-cycle, the
ubisemiquinone (QH·) intermediate which normally reduces low-potential cytochrome b
(cyt bL), instead interacts with oxygen and generates superoxide (Brookes et al., 2004;
Genova and Lenaz, 2015). ROS generated by complex III are released into the
intermembrane space and can be exported to the cytoplasm via the voltage dependent
anion channels (VDACs) (Han et al., 2003). In addition to complex I and III, complex II
(succinate dehydrogenase) has been suggested to be involved in the generation of ROS
by electron transfer back to complex I (Brookes et al., 2004; Genova and Lenaz, 2015).
Other enzymes of oxidative phosphorylation (OXPHO) are also involved in the ROS
generation, in less defined ways.
Although mitochondria generate significant ROS, they also have some self-defense
systems to prevent damage from oxidative stress. For example, in the matrix,
mitochondria have Mn-SOD (SOD2) that converts superoxide to H2O2 (Son et al., 2013).
Mitochondria can use also VDACs or uncoupling proteins UCP2 and 3 to export
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superoxide from the matrix to the cytoplasm (Han et al., 2003; Wojtczak et al., 2011),
thereby preventing the toxic superoxide accumulation within mitochondria.
1.2.2.2 NADPH oxidase (Nox) family
The NADPH oxidase (Nox) family comprises a group of enzymes that depend on
NADPH to reduce oxygen and generate superoxide or hydrogen peroxide. To date, there
are seven enzymes known in mammals, including five Nox isoforms (Nox1, Nox2, Nox3,
Nox4, and Nox5) and two related enzymes, Duox (Dual oxidase) 1 and Duox 2 (Aguirre
and Lambeth, 2010; Katsuyama et al., 2012; Lambeth and Neish, 2014).
Nox2, before called gp91phox, was the first identified Nox enzyme (Royer-Pokora et al.,
1986). Activation of Nox2 oxidase requires the assembly of Nox2 and other regulatory
factors including p22phox, p47phox, p40phox, p67phox, and a small GTP-binding protein, Rac.
Nox1, 3, and 4 also need p22phox. Nox 1 and 3 need additional regulatory subunits
NOXO1 (Nox organizer 1) and NOXA1 (Nox activator 1), but Nox4 is constitutively
active. Nox5, Duox1, and Duox2 are p22phox independent. These three proteins have EF
hand Ca2+ binding domains and are activated by Ca2+. In addition to EF hand Ca2+
binding domains, Duox 1 and 2 contain peroxidase-homology domains and also form
complexes with Duox accessory proteins, DuoxA1 and A2, repectively, to localize on the
membrane (Aguirre and Lambeth, 2010; Katsuyama et al., 2012; Lambeth and Neish,
2014). The primary species of ROS generated by Nox1, 2, 3, and 5 are superoxide,
whereas Nox4, Duox1 and 2 usually produce hydrogen peroxide.
These Nox proteins are involved in the regulation of varied biological processes in
mammals. For example, they play physiological roles in growth, development, cell
motility, muscle contraction, cytoskeleton reorganization, cell survival/apoptosis, stress
adaption, and inflammation (Lambeth and Neish, 2014). In the nervous system, Nox
enzymes are expressed in neurons, microglia, astrocytes, and neuromuscular junctions.
There, they play roles in neural development, neural stem cell biology, and overall neural
function (Nayernia et al., 2014).
In Drosophila, there are just two Nox enzymes. dNox (Drosophila Nox) is the
homologue of mammalian Nox5, containing EF-hand Ca2+ binding domains. dDuox
(Drosophila Duox) is the homologue of mammalian Duox, containing EF-hand Ca2+
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binding domains and peroxidase-homology domains (Ha et al., 2005). These Nox
enzymes are expressed primarily in gut but also in the central nerve system, at lower
levels (Flybase). dNox has been shown to regulate smooth muscle contraction (Ritsick et
al., 2007). In addition, symbiotic lactobacilli can stimulate gut epithelial proliferation via
dNox (Jones et al., 2013). dDuox are involved in gut immunity, which is induced by
bacterial-derived uracil (Ha et al., 2005; Lee et al., 2013). dDuox also regulate the wound
immunity response and stabilize the cuticle structure of the adult wing (Anh et al., 2011;
Razzell et al., 2013).
Thus, ROS are not only toxic for cells, but also play important roles in many biological
processes under physiological conditions.

1.2.3

ROS and transport-related cell signaling

Since ROS have highly reactivity and oxidize other molecules such as proteins, it is
unsurprising that they have roles in the modulation of signaling pathways. One of the
main amino acid residues that can be oxidized is the cysteine residue. When ROS oxidize
cysteine residues and lead the formation of disulfide bond (-SH  -S-S-), it changes
protein activity and/or conformation (Son et al., 2013; Genova and Lenaz, 2015). Among
these ROS-induced signaling pathways, I will focus on two pathways related to axonal
transport (Section 1.1.4.2, above).
1.2.3.1 JNK signaling pathway
c-Jnu N-terminal kinase (JNK), also called stress-activated protein kinase, is one of the
subgroups of the mitogen-activated protein kinase (MAPK) family. In mammals, there
are three isoforms: JNK-1, JNK-2, and JNK-3. JNK-1 and JNK-2 are expressed
ubiquitously, but JNK-3 is expressed mainly in neuronal tissue (Shen and Liu, 2006; Son
et al., 2013).
Like other MAPK family members, JNK is regulated by MAP kinase kinase kinase
(MAPKKK) and MAP kinase kinase (MAPKK). Two MAPKK family members, MKK4
and MKK7 (known as JNKK1/MEK4 and JNKK2/MEK7, repectively) phosphorylate
and activate JNK. MKKs are phosphorylated by numerous MAPKKK, including MEK
kinase 1 (MEKK1), apoptosis signal-regulating kinase 1(ASK1), mixed-lineage kinase
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(MLK), and transforming growth factor-β (TGFβ) activated kinase (TAK). (Shen and Liu,
2006; Son et al., 2013). Downstream targets of JNK include members of the transcription
factor AP-1 familiy (for example, c-Jun), p53, and c-Myc (Shen and Liu, 2006).
In Drosophila, there are one JNK (Basket, Bsk) and two JNKKs (Hemipterous, Hep, a
MKK7 homologue, and dMKK4). These Drosophila JNKKs are also activated by
different MAPKKKs similar to mammals. One of the important downstream genes in the
AP-1 family is puckered (puc), which encodes a JNK-specific phosphatase that inhibits
JNK activity (Biteau et al., 2011).
What are the mechanisms involved in the activation of the JNK pathway by ROS?
ASK1 plays the major role in this regulation. ASK1 has been shown to be a specific
target of ROS since its activation is mediated by two redox-sensitive proteins,
thioredoxin and glutaredoxin (Gotoh and Cooper, 1998; Saitoh et al., 1998; Tobiume et
al., 2001; Song et al., 2002; Song and Lee, 2003). The reduced form of thioredoxin or
glutaredoxin binds to ASK1 and inhibits ASK1 activity. In the presence of ROS,
thioredoxin and glutaredoxin are oxidized and released from ASK1, thereby enhancing
ASK1 activity (Gotoh and Cooper, 1998; Saitoh et al., 1998; Tobiume et al., 2001; Song
et al., 2002; Song and Lee, 2003). Activated ASK1 then initiates the activation of the
ASK1-JNKK-JNK signaling pathway and the expression of the downstream genes (Shen
and Liu, 2006; Biteau et al., 2011; Son et al., 2013) (Fig. 1.5A).
1.2.3.2 PI3K/Akt/GSK3β signaling pathway
The PI3K/Akt signaling pathway is involved in many cellular functions including
protein synthesis, cell cycle, proliferation, and apoptosis in response to growth factors
(Clerkin et al., 2008; Zhang et al., 2016). When growth factors bind and activate receptor
tyrosine kinase (RTK), it recruits phosphoinositide-3-kinase (PI3K). After PI3K is
recruited, PI3K phosphorylates phosphatidylinositol 4,5-biphosphate (PIP2) to form
phosphatidylinositol 3,4,5-biphosphate (PIP3). PIP3 recruits proteins containing
pleckstrin homology (PH) domains, such as phophoinositide-dependent protein kinase
(PDK) and protein kinase B (PKB/Akt). These proteins, PDK and Akt, are
phosphorylated and activated, and then phosphorylate numerous downstream targets (for

20
example, GSK3, FOXO, p53, Bad, and mTOR) (Clerkin et al., 2008; Sullivan and
Chandel, 2014; Zhang et al., 2016) (Fig. 1.5B).
One of the downstream targets is glycogen synthase kinase 3β (GSK3β), a member of
a family of conserved serine/threonine kinases (Hardt and Sadoshima, 2002). GSK3β was
originally named because of its function of phosphorylation of glycogen synthase and
inhibition of glycogen synthesis, but now it has been shown involved in varied cellular
functions (Cohen and Frame, 2001; Hardt and Sadoshima, 2002). GSK3β is the negative
regulator of its downstream targets. Without phosphorylation, GSK3β is active, but
downstream targets are less active. Once GSK3β is phosphorylated, it becomes
inactivated, and thus its downstream targets are active. Thus, activation of PI3K/Akt
stimulates downstream targets via inhibition of GSK3β activity (Cohen and Frame, 2001;
Hardt and Sadoshima, 2002) (Fig. 1.5B).
How is the PI3K/Akt/GSK3β pathway activated by ROS? Since PI3K/Akt/GSK3β is
activated by phosphorylation, this pathway is negatively regulated by phosphatases
(Clerkin et al., 2008; Zhang et al., 2016). One of the well-studied phosphatases,
Phosphatase and Tensin homologue (PTEN), can dephosphorylate PIP3 to PIP2 and
inhibit the PI3K/Akt/GSK3β pathway. PTEN has cysteine residues in the active site. In
the presence of ROS, these cysteine residues are oxidized to form disulfide bonds,
thereby inactivating PTEN. Inactivated PTEN loses the ability to dephosphorylate PIP3
to PIP2, and thereby activates the PI3K/Akt/GSK3β pathway (Clerkin et al., 2008; Zhang
et al., 2016) (Fig. 1.5B).

1.2.4

ROS and Ca2+ homeostasis

Ca2+ is an important second messenger regulating numerous cellular functions such as
muscle contraction, gene expression, cell survival and cell death (Berridge, 2012). Ca2+
can either flow into the cytoplasm through Ca2+ channels or be pumped out of the
cytoplasm by Ca2+ pumps in the plasma membrane or endoplasmic reticulum (ER). Most
of these Ca2+ channels and pumps have cysteine residues that are sensitive to redox status
(Hidalgo and Donoso, 2008; Görlach et al., 2015). Thus, it is no surprise that ROS can
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mediate Ca2+ homeostasis. Here I focus on how ROS mediate Ca2+ homeostasis via these
channels and pumps.
1.2.4.1 Effects of ROS on plasma membrane Ca2+ channels and pumps
Ca2+ enters cells through numerous Ca2+ channels, including voltage-dependent Ca2+
channels (VDCC), and receptor-coupled channels, among these are transient receptor
potential (TRP) channels and the store-operated Ca2+ channels (SOC) mediated by Orai
channel proteins (Görlach et al., 2015).
VDCCs can be oxidized by ROS because of the cysteine residues in their pore forming
α1 subunits (Hudasek et al., 2004). Depending on the channel type, ROS can either
induce or suppress Ca2+ influx via VDCCs (Görlach et al., 2015). For example, ROS
suppress Ca2+ influx in guinea pig ventricular myocytes (Gill et al., 1995), whereas they
stimulate Ca2+ influx through L-type and T-type VDCCs in smooth muscle cells (Tabet et
al., 2004).
TRP channels are a group of Ca2+-permeable cation channels divided into six
subfamilies. They are highly expressed in sensory receptor cells, and important for senses
such as touch, taste, and smell (Voets et al., 2005). In this TRP family, some members
have been shown to be sensitive to redox status (Takahashi and Mori, 2011; Görlach et
al., 2015). TRPM2 was the first channel identified for its ROS-sensitivity. H2O2 has been
shown to activate TRPM2 via the induction of nicotinamide adenine dinucleotide (βNAD+), which directly interacts with TRPM2 (Hara et al., 2002). In addition to TRPM2,
some members, including TRPC5, TRV1, TRPA1, are directly mediated by ROS, NO, or
oxidants via their cysteine residues (Yoshida et al., 2006; Xu et al., 2008; Görlach et al.,
2015).
Store-operated Ca2+ entry (SOCE) is the mechanism by which Ca2+ depletion of the ER
lumen induces Ca2+ influx by activating Ca2+-permeable channels on the plasma
membrane (Shen et al., 2011). When Ca2+ is depleted in the ER, an ER Ca2+ sensor,
STIMs (stromal interaction molecules) move near the plasma membrane and activate
Orai Ca2+ channels on the membrane, thereby inducing Ca2+ influx (Shen et al., 2011).
ROS have been suggested to deplete Ca2+ of ER and activate SOCE (Grupe et al., 2010).
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However, other groups have suggested that ROS inhibit Orai via their cysteine residues
and reduce Ca2+ influx (Bogeski et al., 2010; Bogeski et al., 2012).
The plasma membrane Ca2+ pump, or plasma membrane Ca2+-ATPase (PMCA), is
important for maintaining resting cytoplasmic free Ca2+ concentration, and requires ATP
hydrolysis to actively transport Ca2+. PMCA is activated by the dissociation of its
autoinhibitory domain through the binding of calmodulin (CaM) and PMCA (Hidalgo
and Donoso, 2008). While it remains unclear which residues are sensitive to redox, both
PMCA and CaM have been shown to be sensitive to ROS, which inhibits PMCA activity
(Hidalgo and Donoso, 2008; Zaidi, 2010; Görlach et al., 2015).
1.2.4.2 Effects of ROS on intracellular Ca2+ channels and pumps
Intracellular Ca2+ is released from sarcoplasmic/endoplasmic reticulum (SR/ER)
through two main Ca2+ channels: ryanodine receptors (RyR) in excitable cells; and
inositol 1,4,5-trisphosphate receptors (IP3R) in non-excitable cells (Görlach et al., 2015).
RyR channels play important roles in cellular functions, including muscle contraction,
synaptic activity, secretion, and cell death (Hidalgo and Donoso, 2008). They form
homotetramers in the SR and ER membrane and contain numerous cysteine residues,
rendering them sensitive to redox status (Hidalgo and Donoso, 2008; Görlach et al.,
2015). Oxidation of RyR has been shown to enhance RyR activity and thereby increase
cytoplasmic Ca2+ levels (Hidalgo and Donoso, 2008; Görlach et al., 2015). For example,
oxidation of RyR thiols increases SR Ca2+ leakage (Terentyev et al., 2008) and spark
frequency (Yan et al., 2008).
IP3Rs are important for the regulation of development and fertilization mainly in the
non-excitable cells, but also contribute to in cardiac and neuronal cells (Hidalgo and
Donoso, 2008; Görlach et al., 2015). They are localized in the ER, and are activated by
the binding of the ligand, inositol 1,4,5-triphosphate (IP3). When the IP3 binds to the
IP3R, these channels open and release Ca2+ from the ER to the cytoplasm (Hidalgo and
Donoso, 2008; Görlach et al., 2015). Several oxidants have been shown to activate IP3Rs
by increasing the sensitivity of receptors to the ligands. For example, thimerosal oxidizes
cysteine residues and stabilizes the active form of the IP3Rs (Bootman et al., 1992; Khan,
2013). Diamide also induces S-glutathionylation of the receptors and increases
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intracellular Ca2+ levels (Lock et al., 2011). Thus, IP3Rs can be activated even IP3 levels
are low.
The primary intracellular Ca2+ pumps are the sarcoplasmic/endoplasmic reticulum Ca2+
ATPase (SERCA). SERCA contains many cysteine residues (from 22 to 28 cysteines,
depending on different isoforms), so it is sensitive to redox (Hidalgo and Donoso, 2008;
Görlach et al., 2015). Several studies indicate that ROS inhibit SERCA activity via
cysteine or tyrosine residues (Xu et al., 1997; Barnes et al., 2000; Brookes et al., 2004).
In addition, since SERCA pumps require ATP for their activity, it is notable that ROSoxidized SERCAs reduce their ability to bind ATP and thus lose activity (Sharov et al.,
2006; Cook et al., 2012). Thus, in the presence of ROS, active Ca2+ transport by SERCAs
is inhibited.

1.2.5

ROS and neurodegenerative diseases

ROS have been shown to be associated with several neurodegenerative diseases. Most
studies and reviews in this area focus on Alzheimer’s disease and Parkinson’s disease
(Zhao and Zhao, 2013; Bhat et al., 2015; Blesa et al., 2015; Kim et al., 2015).
As mentioned in section 1.1.5, neuritic plaques containing Amyloid-β aggregates and
neurofibrillary tangles containing hyperphosphorylated Tau proteins are two pathological
hallmarks of Alzheimer’s disease. Amyloid-β has been shown to increase H2O2 levels
(Behl et al., 1994). In transgenic mouse models with overexpression of mutant amyloid
precursor protein (APP), accumulated Amyloid-β evokes oxidative stress (Smith et al.,
1998; Matsuoka et al., 2001). On the other hand, oxidative stress apparently increases the
production of Amyloid-β oligomerization or plaque. In the transgenic mouse models,
deletion of antioxidant enzymes, SOD1 or 2, increases Amyloid-β oligomerization or
plaque formation (Li et al., 2004; Murakami et al., 2011), and overexpression of SOD2
reduces oxidative stress and also decreases Amyloid-β plaque (Dumont et al., 2009). In
addition to Amyloid-β, tau proteins are associated with oxidative stress. Tau has been
shown to both block vesicle traffic and to enhance oxidative stress (Stamer et al., 2002),
and oxidative stress enhances tau-induced neurodegeneration in a Drosophila model
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(Dias-Santagata et al., 2007). Overall, these studies provide evidence that oxidative stress
is highly interrelated with Alzheimer’s disease.
Parkinson’s disease is characterized by the selective loss of dopaminergic (DA)
neurons in the substantia nigra pars compacta (SNpc). One class of factors inducing
Parkinson’s disease is environmental toxins. Some toxins, such as MPTP (or its
derivative MPP+) and rotenone that are the inhibitors of mitochondrial complex I, are
preferentially toxic to the DA neurons (Blesa and Przedborski, 2014). They inhibit the
normal activity of complex I, disrupt the electron transport chain, and produce ROS
mainly in the DA neurons, thereby inducing Parkinson’s disease (Mizuno et al., 1987;
Betarbet et al., 2000). Paraquat is also preferentially toxic to DA neurons by activating
NOX in microglia cells. In both in vitro and in vivo systems, paraquat neurotoxic actions
to DA neurons in microglia cells is inhibited if NOX is deficient (Wu et al., 2005; Purisai
et al., 2007). The pathological hallmark of both familial and sporadic Parkinson’s disease
is the accumulation of the protein α-synuclein. It has been shown that this accumulation
increases oxidative stress in DA neurons (Martin et al., 2006). Furthermore, oxidative
stress also induces accumulation and oligomerization of α-synuclein in oligodendrocytes
or brain slice cultures (Xu et al., 2013; Pukass and Richter-Landsberg, 2014), suggesting
that oxidative stress and Parkinson’s disease are highly associated in a feed-forward
manner. Mutations linked to the familial Parkinson’s disease are also linked to ROS. For
example, PINK1 mutations have been shown to induce abnormal mitochondrial
morphology and enhance vulnerability to ROS (Clark et al., 2006; Gautier et al., 2008),
and that is rescued by downstream Parkin expression (Yang et al., 2006; Exner et al.,
2007).
Overall these numerous studies show that one of the factors inducing
neurodegenerative disease is ROS, while the detailed mechanism remains unclear. Thus,
it is important to find the fundamental connections between these two.

1.2.6

ROS and mitochondrial axonal transport

As mentioned above (Sections 1.1.5 and 1.2.5), ROS and impaired axonal transport of
mitochondria are both implicated in neurodegenerative diseases. However, it is still not
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clear whether or how ROS directly affect mitochondrial transport. Recent studies have
shown that the H2O2 donor, tert-butyl hydroperoxide, or H2O2 treatment itself in cell
culture systems leads to the reduction of organelle transport (Isonaka et al., 2011; Fang et
al., 2012). In addition, an SOD1 mutant has been shown to reduce mitochondrial
transport in vitro (Song et al., 2012). Whether these effects occur in the more complex,
homeostatic, and normoxic in vivo environment remains unknown. Moreover, the
mechanisms involved in the regulation of mitochondrial transport in the presence of ROS
are still unclear.
Thus, in this study I used primary Drosophila neuronal cell culture and the third instar
larval nervous system as in vitro and in vivo models, respectively, to elucidate the
mechanistic connections between ROS and mitochondrial transport.
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Figure 1.4. ROS and antioxidant systems. When oxygen is one-electron reduced,
oxygen converts to superoxide anion (O2-·). Two-electron reduction leads to hydrogen
peroxide (H2O2) formation. A further one-electron reduction of hydrogen peroxide forms
the highly reactive hydroxyl radical (OH·). Cells have antioxidant enzymes. SOD
converts O2-· to H2O2; CAT and GSH Px convert H2O2 to H2O. Other antioxidants (some
shown in the box) are also involved in the regulation of redox balance (Song et al., 2013).
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Figure 1.5 ROS regulation of the JNK and the PI3K/Akt/GSK3β pathway. A, ROS
oxidize the cysteine residues of Trx or Grx, which activates ASK1 because of the
dissociation of Trx or Grx. Activated ASK1 then phosphorylates downstream proteins
and thereby activates the JNK pathway. B, ROS activate the PI3K/Akt/GSK3β pathway
via the inhibition of the phosphatase PTEN. GSK3 is the negative regulator of the
downstream targets. Activation of the Akt phosphorylates and inhibits GSK3 activity,
and thereby activates the downstream targets.
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CHAPTER 2. MATERIALS AND METHODS

2.1

2.1.1

Materials and chemicals

Materials for in vivo studies

Dissecting microscope (Nikon SMZ645), Scissors (Fine Science Tools- FST # 1500000 straight), two pairs of forceps (FST, Dumont #5 Dumonstar # 11295-00), Sylgard
plate (Sylgard 182 Silicone Elastomer Kit), Minutien insect pins (FST # 26002-10), glass
slides (Rite-On microslides Cat # 3050, size 25mm X 75mm), coverslips (24 X 40 mm
No.1, VWR Cat #16004-306) , double sided permanent tape (Scotch Cat # 137DM-2 or
3M with 0.5 inch thickness), VALAP (Vaseline, Lanolin and Paraffin wax in equal parts)
heated to 75°C, and small art paint brush.

2.1.2

Materials for in vitro studies

Dissecting microscope (ZEISS STEMI SR), two pairs of forceps (FST, Dumont #5
Dumonstar # 11295-00), Sylgard plate (Sylgard 182 Silicone Elastomer Kit), glass slides
(Rite-On microslides Cat # 3050, size 25mm X 75mm), coverslips (VWR micro cover
glass), double sided permanent tape (Scotch Cat # 137DM-2 or 3M with 0.5 inch
thickness), VALAP (Vaseline, Lanolin and Paraffin wax in equal parts) heated to 75°C,
and small paint brush.

2.1.3

Chemicals for in vivo studies

HL6 buffer (Hemolymph-Like buffer): 23.7 mM NaCl (Mallinckrodt chemicals), 24.8
mM KCl (Sigma), 15 mM MgCl2·6H2O (Mallinckrodt chemicals), 10 mM NaHCO3
(Sigma), 20 mM Isothionic acid sodium salt (Sigma), 5 mM BES (Sigma), 80 mM
Trehalose dehydrate (Sigma), 5.7 mM L-Alanine (Sigma), 2 mM L-Arginine

29
monohydrochloride (Sigma), 14.5 mM Glycine (Sigma), 11 mM L-Histidine (Sigma),
1.7 mM L-Methionine (Sigma), 13 mM L-Proline (Sigma), 2.3 mM L-Serine (Sigma),
2.5 mM L-Threonine (Sigma), 1.4mM L-Tyrosine (Sigma), 1 mM L-Valine (Sigma), 0.6
mM CaCl2 Dihydrate (Sigma;), 4 mM L-Glutamate monosodium salt hydrate (Sigma)
Paraquat (Sigma)

2.1.4

Chemicals for in vitro studies

Schneider’s medium (Gibco), 10% heat-inactivated Fetal bovine serum (FBS, Atlanta
Biologicals),

Pen-Strep (50 U/mL penicillin with 50 μg/mL streptomycin, Gibco),

collagenase (Sigma), concanavalin A (Sigma), tetramethylrhodamine methyl ester
(TMRM, Life Technologies, Molecular Probes) , hydrogen peroxide 30% solution (H2O2,
Macron Fine Chemicals), ethylene glycol tetraacetic acid (EGTA, Sigma), BAPTA-AM
(Sigma)
Ca2+/Mg2+ free saline: 137 mM NaCl, 2.7 mM KCl, 0.36 mM NaH2PO4·H2O, 11.9
mM NaHCO3, 5.6 mM glucose
S2 saline: 120 mM NaCl, 5 mM KCl, 8 mM MgCl2, 2 mM CaCl2, 10 mM HEPES

2.2

Drosophila lines and maintenance

All Drosophila Stocks were maintained on normal fly food at 25°C with 40%-60%
humidity and a 12 hr light/dark cycle. Fly genotypes used in this study are shown in the
table (Table 2.1).
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Table 2.1 Genotypes of flies in this study
Number

Fly genotypes

Source

1

+; D42-Gal4, UAS-mitoGFP

Leo J. Pallanck (University
of Washington)

2

sp/Cyo; D42-Gal4, UAS-ANF-GFP

William M. Saxton (UC
Santa Cruz)

3

+; D42-Gal4

Leo J. Pallanck (University
of Washington)

4

UAS-SOD1;+

Bloomington stock center

5

UAS-SOD2;+

Bloomington stock center

6

UAS-SOD1; D42-Gal4, UAS-mitoGFP

Generated from #1 and #4

7

UAS-SOD2; D42-Gal4, UAS-mitoGFP

Generated from #1 and #5

8

UAS-GCaMP6m;+

Bloomington stock center

9

UAS-GCaMP6m/+; D42-Gal4/+

Generated from #3 and #8

10

UAS-HepB2;+

Bloomington stock center

11

UAS-Bsk RNAi;+

Vienna

Drosophila

RNAi

Center (VDRC)
12

UAS-HepB2; D42-Gal4, UAS-mitoGFP

Generated from #1 and #10

13

UAS-Bsk RNAi; D42-Gal4, UAS-mitoGFP

Generated from #1 and #11

14

UAS-HepB2/UAS-GCaMP6m; D42-Gal4/+

Generated from #9 and #10

15

UAS-Bsk RNAi /UAS-GCaMP6m; D42- Generated from #9 and #11
Gal4/+

16

UAS-Nox RNAi/+

Vienna

Drosophila

RNAi

Center (VDRC)
17

UAS-Duox RNAi/+

Vienna

Drosophila

RNAi

Center (VDRC)
18

UAS-Nox RNAi; D42-Gal4, UAS-mitoGFP

Generated from #1 and #18

19

UAS-Duox RNAi; D42-Gal4, UAS-mitoGFP Generated from #1 and #19
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2.3

Preparation of primary neuronal cell culture and dissected larvae for live
imaging

2.3.1

Preparation of Drosophila larval primary neuronal culture

Prior to dissection, 4 third-instar larvae were washed with 70% ethanol once and
endotoxin-free water for three times. Larvae were dissected in Schneider’s medium by
pulling the mouth hook, which opened the animal’s body and exposed the brains and
ventral ganglia. After cleaning away debris, the brains and ventral ganglia were incubated
in Ca2+/Mg2+ free saline with 0.7 mg/ml collagenase for 1 hr at room temperature.
Samples were centrifuged at 300 g for 3 min and washed once with Schneider’s medium.
Tissue was then triturated with siliconized pipette tips to disperse it into individual cells,
which were then plated on coverslips coated with 15 µg/ml concanavalin A and incubated
in Schneider’s medium containing 1% FBS in a humidified chamber at 25°C for 72 hrs.
Before imaging, 50 µl of Schneider’s medium was placed on a glass slide with a single
layer of double-sided tape as a spacer. The coverslip with cells was flipped onto the glass
slide. The sample was then sealed with VALAP and ready for imaging.

2.3.2

Drosophila larval dissection for live imaging

Third instar larvae were prepared using methods described previously (Pilling et al.,
2006; Devireddy et al., 2014; Devireddy et al., 2015). First, third instar larvae were
washed with distilled water and pinned at posterior and anterior ends with the dorsal side
up on a slygard plate (Fig. 2.1A), and moistened with HL6 buffer. A small hole was cut
at the posterior end of the body (Fig. 2.1B) and the larva was opened by snipping through
the cuticle with dissecting scissors (Fig. 2.1C). Muscles and fat bodies were removed
exposing the brain, ventral ganglion, and the intact segmental nerves (Fig. 2.1D), which
retained their connections to the muscles of the body wall. To make the larva lie flat, 4
small lateral cuts (2 close to the anterior end and 2 close to the posterior end) were made
in the body wall (Fig. 2.1E). The dissected larva was then moved and opened gently onto
a glass slide containing two layers of double-sided tape as spacers (Fig. 2.1F), and the
ventral ganglion and the segmental nerves were stretched by gently holding the mouth
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hook (Fig. 2.1G, H). This sample was then covered by a coverslip, incubated in HL6
buffer, and the resulting chamber was sealed with VALAP. The whole procedure was
done in 10 minutes.

2.3.3

ROS induction in vitro and in vivo

To induce oxidative stress in vitro, cells were treated with 100 µM H2O2 for 1 hr,
followed by imaging (Fang et al., 2012). To induce oxidative stress in vivo, second to
third instar larvae were starved for 3 hr and then maintained on the standard fly food
containing 20 mM paraquat for 24 hrs (Lee et al., 2009), followed by dissection and
imaging.

Figure 2.1. Steps of in vivo larval dissection. A, Larva is pinned on a slygard plate at
anterior and posterior positions. B, An incision is made at the posterior end. C, Larva is
opened by cutting through the cuticle on the dorsal side. D, Fat bodies and muscles are
cleaned to expose intact nervous system. E, Small lateral incisions are made to flatten the
larva (4 positions at anterior and posterior ends, only shown one position here). F, Larva
is transferred to a glass slide and body walls are opened (red arrow). G and H, Bright
field and fluorescence images of dissected larva are shown. (Figure is adapted and
modified from Devireddy et al., 2014)
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2.4

2.4.1

Analysis of mitochondrial and dense core vesicle (DCV) transport

Acquisition of time lapse confocal images

In vitro, mitochondria or DCVs were imaged using 60x oil-immersion objective lens
and 3x zoom of the upright, time-lapse laser confocal microscope (LSCM, Nikon Eclipse
90i) with a 488 nm laser (5%; 150mW laser power). The time resolution was 1 frame/s
for a duration of 120 s. Transport of DCVs was also visualized using spinning disk
confocal microscopy (Olympus IX-71 microscope equipped with a 60X 1.45 NA TIRFM
PlanApo objective and Disk Scanning Unit). The time resolution in this case was 5
frames/s for a duration of 120 s (Fig. 2.2A, B).
In vivo, time lapse confocal images of mitochondrial or DCV transport were acquired
in the middle segment (A4 region) of the longest larval segmental nerves using LSCM
with a 488 nm laser. The time resolution was 1 frame/s for a duration of 200 s (Fig. 2.2C
– E).

2.4.2

In vitro analysis of mitochondrial and DCV transport

For mitochondrial transport, the percentage of moving mitochondria was analyzed. The
number of the moving or stationary mitochondria was counted using the Cell Counter
plug-in in Image J software.
For DCV transport, due to the fast transport behavior, flux and velocity were analyzed
from kymographs created by MetaMorph software. Flux is the number of vesicles
passing an assigned point in a 60 sec period. Velocity is the average of the instantaneous
velocity. I analyzed the flux by counting the number of the moving organelle tracks
passing through the vertical midline of the kymograph. Velocity was calculated from the
slope of the lines in kymographs. Anterograde transport is defined as the transport toward
synaptic terminals; retrograde transport is defined as the transport toward to cell bodies.

2.4.3

In vivo analysis of mitochondrial and DCV transport

Kymographs of mitochondrial or DCV transport in vivo were prepared using Nikon
NIS-Elements software. Manual Tracking plug-in in Image J software was used to track
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individual mitochondria or DCVs by marking the x-y positions of every vesicle in every
frame. A stationary vesicle was also “tracked” as a reference point to eliminate the effects
of larval moving or stage drift. These positional data were used to analyze different
parameters of transport behavior described as follows (Devireddy et al., 2014; Devireddy
et al., 2015):
1. Run is the motion sustained in at least three frames with the velocity larger than
0.1 μm/s or smaller than -0.1μm/s.
2. Flux is defined as the number of vesicles that cross an assigned point in oneminute interval. In a 200 s period, I recorded how many mitochondria moved
anterogradely and retrogradely across a line drawn in the center of the movie
frame.
3. Velocity is the average of velocity of each run. Velocity was considered as run
velocity only rather than average velocity including pauses. This run velocity was
determined by the total length/total time of all runs.
4. The percentage of moving vesicles is the fraction of vesicles that move either
anterogradely or retrogradely. Cell Counter pulg-in was used to count the number
of moving or stationary mitochondria.
5. Duty cycle is the percentage of time spent moving in a particular direction,
anterograde, retrograde, or paused.
6. Run length is the average moving distance per run. Typically I used total distance
of total runs/the number of runs to get average run length.
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Figure 2.2. GFP expression of mitochondria or DCVs in vivo and in vitro. A and B,
Mitochondria (A) and DCVs (B) are shown in primary neuronal cell culture. C, all 8
segments, segmental nerves (SNs), and ventral ganglion (VG) are shown. The white box
shows the A4 (Abdominal segment 4) region of the longest segmental nerves, used for
visualizing transport. D and E, Mitochondria (D) and DCVs (E) are shown in the A4
region of the longest segmental nerves. Scale bars in (A,B,D,E) indicates 10 µm. (Figure
is adapted and modified from Devireddy et al., 2014)
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2.5

2.5.1

Measurement of mitochondrial membrane potential

TMRM treatment in cell culture

A 20 mM tetramethylrhodamine methyl ester (TMRM) stock was prepared in DMSO.
A 25 µM TMRM working stock was prepared freshly for each experiment by diluting the
first stock with DMSO. Cells were incubated in Schneider’s medium containing 25 nM
TMRM for 10 minutes, and washed once with 6.25 nM TMRM washing solution. The
treated samples were imaged in washing solution to maintain dye equilibrium. All
procedures were performed avoiding light exposrue (Shidara and Hollenbeck, 2010;
Devireddy et al., 2014; Devireddy et al., 2015).

2.5.2

Imaging and quantification of TMRM intensity

Cells were imaged using 60x oil-immersed objective lens with 3x zoom of confocal
microscope (Nikon Eclipse 90i) with 5% 488 nm and 561 nm laser. To image motor
neurons specifically, cells containing green signals due to the expression of mitoGFP
driven by D42-Gal4 were selected .The laser power of the 561 nm channel was
sometimes adjusted to prevent saturated exposure in the images.
To quantify the TMRM intensity, images were thresholded in the intensity range
between 350 and 4095 units (highest intensity: 4095) and the intensity of mitochondrial
fluorescence (Fm) was measured using Nikon NIS-Elements software. The fluorescence
intensity in cytosol (Fc) was determined as the average intensity of two 5 pixel x 5 pixel
regions next to the mitochondria. The mitochondrial membrane potential was then
expressed as the intensity ratio of mitochondrial fluorescence to cytosolic fluorescence
(Fm/Fc) which is logarithmically related to mitochondrial membrane potential.

2.6

2.6.1

Quantification of mitochondrial density and lengths

Quantification of mitochondrial density

Mitochondrial density was determined by finding the total mitochondrial pixels in
fields imaged in the center of segmental nerves (A4) using MetaMorph software. The
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second frame of the time lapse images was used to reduce background noise and sharpen
the image by low-pass Laplace filters in the software. Then the image was thresholded at
350 intensity units and binarized. From this binary image, integrated mitochondrial pixels
(number of mitochondrial pixels divided by total pixels in the nerve field) were measured
as mitochondrial density.

2.6.2

Quantification of mitochondrial length

In cell culture, only mitochondria in the processes were selected for length
measurement. Mitochondrial length was measured using Annotations and Measurements/
Length/2 Points or Polyline function in Nikon NIS-Elements software.

2.7

2.7.1

Measurement of Ca2+ levels and analysis of transport affected by Ca2+

Ca2+ chelation and release in cell culture

Neuronal cells expressing GCaMP6 in motor neurons (UAS-GCaMP6m/+; D42Gal4/+) were used to visualize Ca2+ levels. Before treatment, cells were washed three
times with sterile S2 saline. To chelate extracellular Ca2+, cells were incubated in Ca2+free saline (S2 saline without CaCl2) containing 0.1 mM EGTA for 30 minutes. To
remove both extracellular and intracellular Ca2+, cells were incubated in Ca2+-free saline
containing 0.1 mM EGTA and 10 µM BAPTA-AM for 30 minutes (Kim and Sharma,
2004; Yeromin et al., 2004; Huang et al., 2014). To induce ROS in Ca2+ chelation
conditions, cells were incubated in above-described solutions containing 100 µM H2O2
for 1 hr. After incubation, cells were prepared for imaging.
To artificially increase intracellular Ca2+ levels dramatically, cells were treated with S2
saline containing 10 µM ionomycin, an ionophore. To induce intracellular Ca2+ levels
from the intracellular Ca2+ pool, cells were treated with S2 saline containing 2 µM
thapsigargin, an ER Ca2+-ATPase inhibitor (Yeromin et al., 2004). After treatment, cells
were imaged immediately.
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2.7.2

Imaging and quantification of Ca2+ levels

Cells were imaged using a 60x oil-immersion objective lens with 3x zoom on the
confocal microscope (Nikon Eclipse 90i) using 10% power from the 488 nm laser. To
image motor neurons specifically, cells containing green signals due to the expression of
GCaMP6 driven by D42-Gal4.were selected.
To quantify the Ca2+ levels, images were thresholded in the intensity range between 30
and 4095 units (highest intensity: 4095) and the intensity of Ca2+ was measured in whole
cells using Nikon NIS-Elements software. Total intensity/total area was used to get the
average intensity of Ca2+ in a cell.

2.7.3

Imaging the effects of Ca2+ on transport

To determine the effects of elevated Ca2+ on mitochondrial or DCV transport, 10 µM
ionomycin or 2 µM thapsigargin was used as in section 2.7.1, above. Before treatment,
cells were washed with S2 saline for three times and imaged using the in vitro settings as
in section 2.4.1, above. The same sample was then treated with S2 saline containing 10
µM ionomycin or 2 µM thapsigargin. After treatment, the same cell was imaged again
immediately. To analyze transport, the percentage of mitochondria transport or velocity
of DCV of the same cell before and after treatment was analyzed using the methods
described in section 2.4.2, above.
To determine the effects of Ca2+ chelation on mitochondrial transport, conditions of
treatment were the same as in section 2.7.1, above. The settings for the acquisition and
analysis were the same as in sections 2.4.1 and 2.4.2, respectively.

2.8

Statistics

All statistical analysis was performed using GraphPad Prism 5 software. All error bars
in graphs indicate mean ± SEM. In the in vivo studies, the experimental unit is an
individual larva. In the in vitro studies, the experimental unit is a cell. Data were analyzed
using a one-way ANOVA with Bonferroni’s post-test for multiple group comparisons,
paired or unpaired Student’s t-test for two group comparisons. In all cases, at least three
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independent experiments were performed. The specific type of statistical analysis was
shown in figure legends.
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CHAPTER 3. RESULTS

3.1

3.1.1

Mitochondrial transport in axons is reduced in response to oxidative stress

Mitochondrial transport is reduced in vitro in response to oxidative stress

Impairment of the axonal transport of mitochondria has been shown to correlate
with neurodegenerative diseases (Saxton and Hollenbeck, 2012; Sheng and Cai,
2012). However, how ROS production might circle back to regulate mitochondrial
transport, an issue that may be important in the pathophysiology of neurodegeneration,
is still unknown. Diminished overall mitochondrial transport under oxidative stress
conditions has been shown in cultured neurons (Fang et al., 2012). Thus, I first
examined whether oxidative stress affected mitochondrial transport in Drosophila
primary neuron cell cultures obtained from brains and ventral ganglia of third instar
larvae expressing mtiochondrially-targeted GFP in motor neurons.
To induce oxidative stress, I treated cells with 100 µM H2O2 for 1 hr and found that
the percentage of moving mitochondria in axons decreased significantly (Fig. 3.1A,
B). Longer periods of treatment (up to 3 hrs) did not produce any further reduction in
mitochondrial motility (Fig. 3.1C). These results indicate that in Drosophila primary
neuronal cell cultures, mitochondrial transport is diminished under conditions of
oxidative stress, consistent with previous in vitro studies (Fang et al., 2012).

3.1.2

Mitochondrial transport is reduced in vivo in response to oxidative stress

Although the results showed that oxidative stress reduced mitochondrial transport
in cultured neurons, it remained unknown whether or not ROS affect mitochondrial
transport in axons of the nervous system in vivo. In the more complex in vivo
environment, homeostatic control of ROS is probably more robust, and physiological
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pO2 is lower than in vitro. Thus, I quantified different parameters of mitochondrial
transport under oxidative stress conditions in vivo in 3rd instar larvae expressing
mito-GFP in their motor neurons and prepared as previously described (Shidara et al,
2010; Devireddy et al, 2014). I expected that, as in vitro, an in vivo ROS increase
would affect mitochondrial transport. To induce oxidative stress in the larval nervous
system, I treated larvae with 20 mM paraquat for 24 hrs (Lee et al., 2009), and
quantified mitochondrial movements in axons in the central region of the longest
segmental nerves (Devireddy et al., 2014).
In axons, moving mitochondria are categorized into anterograde and retrograde
populations by their dominant and net direction of movement, which is easily
distinguishable despite pauses and brief reversals of direction. I first quantified flux,
which is a gross indicator of movement representing how many mitochondria pass a
fixed point per unit time. I found reduced mitochondrial flux in both the anterograde
and retrograde populations after paraquat treatment in vivo (Fig. 3.2A, B). To perform
a more detailed analysis and determine the possible mechanisms decreasing flux, I
examined more specific parameters of mitochondrial transport: velocity, duty cycle,
run length, percentage of moving mitochondria, and density (Devireddy et al., 2014).
Under oxidative stress conditions, I found reduced run velocities in both directions
(Fig. 3.2C), of a magnitude nearly large enough to explain the reduction in flux. In
addition, duty cycle was modestly-reduced in the retrograde direction (Fig. 3.3A).
Due to the reduction of velocity and duty cycle, retrograde run length was also
modestly reduced (Fig. 3.3B). Moreover, reduced flux was caused by an increased
percentage of stationary mitochondria (Fig. 3.3C). Mitochondrial density is not
directly linked to motility, but reduced density can definitely contribute to reduced
flux. However, there was no significant difference in mitochondrial density of
segmental nerve axons under oxidative stress conditions (Fig. 3.3D), indicating that
mitochondrial motility is directly reduced under these conditions in vivo.
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3.2

Overexpression of SOD attenuates defects of mitochondrial transport
under oxidative stress conditions

3.2.1

Overexpression of SOD rescues ROS-induced defects of mitochondrial
transport in vitro

Superoxide dismutase (SOD), a well-characterized anti-oxidant enzyme, converts
superoxide to H2O2 (Matés et al., 1999; Fischer et al., 2012). Overexpression of SOD
has been shown to relieve oxidative stress in Drosophila (Parkes et al., 1998; Elia et
al., 1999). To ensure that the reduced mitochondrial transport observed above was
specifically caused by oxidative stress, I overexpressed cytosolic SOD (SOD1) or
mitochondrial SOD (SOD2) under oxidative stress conditions, with the expectation
that ROS-induced defects in mitochondrial transport would be rescued. As expected,
the defects in the percentage of moving mitochondria in vitro were fully rescued by
overexpression of either SOD1 or SOD2 (Fig. 3.1A, B), indicating that the defects of
mitochondrial transport were specifically caused by oxidative stress in vitro.

3.2.2

Overexpression of SOD rescues ROS-induced defects of mitochondrial
transport in vivo

In vivo, both the reduced flux and velocity produced by paraquat were rescued by
SOD1 or 2 overexpression (Fig. 3.2). In the retrograde direction, both the modestlyreduced duty cycle and run length were also rescued (Fig. 3.3A, B). For the
percentage of moving mitochondria in vivo, the increase in stationary mitochondria
was rescued (Fig. 3.3C). Interestingly, SOD2 overexpression alone produced an
increase in the percentage of anterograde moving mitochondria. In addition, under
oxidative stress conditions, SOD2 overexpression produced an increased percentage
of retrograde moving mitochondria (Fig. 3.3C), suggesting that mitochondrial SOD
overexpression could play a role in recycling mitochondria back to cell bodies. These
results indicate that inducing a reduction of excess ROS levels can diminish the
defects in mitochondrial transport in vivo. On the other hand, there is no significant
difference in axonal mitochondrial density compared to controls with SOD1 or 2
overexpression alone (Fig. 3.3D), suggesting that mitochondrial biogenesis, turnover,
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and/or the traffic steady state were not affected by the overexpression. In sum, these
results indicate that excess ROS do produce defects of mitochondrial transport both in
vitro and in vivo.
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Figure 3.1. The percentage of moving mitochondria is reduced in response to
ROS and rescued by SOD overexpression in vitro. A, Representative kymographs
of mitochondrial transport under H2O2 treatment. Anterograde transport is toward the
right; retrograde transport is toward the left. B, The percentage of moving
mitochondria is reduced with H2O2 treatment. SOD1 or SOD2 overexpression can
rescue the defect. C, The percentage of moving mitochondria decreases with the same
levels after H2O2 treatment for 1 to 3 hrs. Number of cells is shown on bars. Error
bars indicate mean ± SEM. Significance is determined by one-way ANOVA with
Bonferroni’s post-test. *p<0.05, **p<0.01, and ***p < 0.001.
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Figure 3.2. ROS change mitochondrial motility mainly by reducing flux and
velocity in vivo. A, Representative kymographs of mitochondrial transport under
paraquat treatment. Anterograde transport is toward the right; retrograde transport is
toward the left. B, Paraquat treatment produces a decrease in mitochondrial flux,
which is rescued by overexpression of SOD1 or SOD2 in both directions. C, Velocity
is reduced with paraquat treatment, which is rescued by SOD1 or SOD2
overexpression in both directions. Number of larvae is shown on bars. Error bars
indicate mean ± SEM. Significance is determined by one-way ANOVA with
Bonferroni’s post-test. *p<0.05, and ***p < 0.001.
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Figure 3.3. ROS modestly affect mitochondrial duty cycle, run length, and
percentage of moving mitochondria in vivo. A, Paraquat treatment gives a small
reduction in retrograde duty cycle with an increase of pause time and a decrease of
moving time; overexpression of SOD1 shows a small increase of pause time. B,
Retrograde run length is modestly reduced with paraquat treatment. C, Paraquat
treatment shows an increase of the percentage of stationary mitochondria, which is
rescued by SOD overexpression. The percentage of anterograde moving mitochondria
increases with SOD2 overexpression. D, Mitochondrial density is comparable to
control with paraquat treatmen or SOD overexpression. Number of larvae is shown
on bars. Error bars indicate mean ± SEM. Significance is determined by one-way
ANOVA with Bonferroni’s post-test. *p<0.05, and **p < 0.01.
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3.3

Transport of neuropeptide-bearing large DCVs is barely affected in the
presence of ROS

3.3.1

DCV transport is barely affected in response to oxidative stress in vitro

To test whether the defects of transport in response to oxidative stress are specific
to mitochondria, I further investigated fast axonal transport of other cargoes. To
examine this, ANF (atrial natriuretic peptide)-GFP, a GFP fusion targeted to the
lumen of neuropeptide-bearing DCVs, was expressed in motor neurons using the
D42-Gal4 driver (Barkus et al., 2008).
In vitro, time lapse images were taken using a spinning disk confocal microscope
with 5 frames/s time resolution. Then images were converted to kymographs for
analysis of flux and velocity (Fig. 3.4A). Under oxidative stress conditions, the flux
of DCV transport was not affected in either direction (Fig. 3.4B). Velocity analysis
showed that only retrograde, but not anterograde, velocity was modestly affected (Fig.
3.4C). These results indicate that DCV transport is barely affected under oxidative
stress conditions in vitro.

3.3.2

DCV transport is not affected in response to oxidative stress in vivo

In vivo, detailed parameters of DCV transport in response to ROS -- including
velocity, duty cycle, run length, and density -- were analyzed (Fig 3.5). As with the in
vitro results, all of parameters under paraquat treatment were comparable to controls,
indicating that DCV transport is not affected by oxidative stress conditions (Fig 3.5BD). In addition, since the DCV density is unchanged (Fig. 3.5E), DCV biogenesis and
degradation appear to be maintained in their normal steady state. Thus, based upon
both in vitro and in vivo results, I conclude that oxidative stress impedes
mitochondrial transport specifically, rather than the general axonal transport of
organelles.
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Figure 3.4. DCV transport is nearly unaffected by ROS treatment in vitro. A,
Representative kymographs of DCV transport in vitro. Anterograde transport is
toward the right; retrograde transport is toward the left. B, There is no significant
difference in both anterograde and retrograde flux of DCV transport with H2O2
treatment. C, Retrograde velocity of DCV transport is reduced with H2O2 treatment.
Number of plates is shown on bars. Each plate contains at least 5 cells. Error bars
indicate mean ± SEM. Significance is determined by Mann Whitney test. **p < 0.01.
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Figure 3.5. DCV transport is unaffected by ROS treatment in vivo. A,
Representative kymographs of DCV transport in vivo. Anterograde transport is
toward the right; retrograde transport is toward the left. B-E, Parameters in DCV
transport with paraquat treatment including velocity (B), duty cycle (C), run length
(D), and density (E) are comparable to controls. Number larvae is shown on bars.
Error bars indicate mean ± SEM. Significance is determined by Student’s t-test.
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3.4

Endogenous Nox and Duox play roles in the regulation of mitochondrial
transport

It has been shown that excessive ROS induce oxidative stress and cellular damage.
However, recent evidence makes it clear that endogenous ROS are important
signaling molecules required for different functions such as wound response, muscle
contraction, and neurite outgrowth, among other roles. (Ritsick et al., 2007; Razzell et
al., 2013; Munnamalai et al., 2014; Nayernia et al., 2014). So aside from excessive
ROS, it is unclear whether endogenous ROS levels also affect mitochondrial transport
in axons. To examine this, NADPH oxidase (Nox) and Dual oxidase (Duox) were
down-regulated by RNAi in motor neurons and mitochondrial transport was
examined in vivo.
I examined different parameters including flux, velocity, duty cycle, run length,
percentage of moving mitochondria and density in both directions under Nox or Duox
down-regulation (Fig. 3.6 and 3.7). Interestingly, all transport parameters were
reduced in both directions with Nox down-regulation (Fig. 3.6 and 3.7), indicating
that endogenous ROS are required for mitochondrial transport. On the other hand,
only retrograde mitochondrial transport showed a general reduction with Duox downregulation (Fig. 3.6 and 3.7), suggesting a directional difference of influence between
Duox and Nox. Furthermore, only run length decreased in the anterograde direction
(Fig. 3.7B), suggesting that the specific motility pattern is affected by Duox
knockdown. Mitochondrial density under down-regulation of Nox or Duox was
comparable to controls, indicating the observed defects were due to transport
behavior. These data suggest that either abnormally high or low levels of ROS affect
mitochondrial movement in axons, implying that physiological ROS levels are crucial
for mitochondrial transport. This also raises the possibility that the defects of
mitochondrial transport observed under conditions of excessive ROS are caused not
only by oxidative damage but also by the subversion of ROS-induced signaling
pathways.
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Figure 3.6. Endogenous ROS affect mitochondrial flux and velocity in vivo. A,
Representative kymographs of mitochondrial transport with knockdown of Duox or
Nox. Anterograde transport is toward the right; retrograde transport is toward the left.
B, Knockdown of Duox produces a decrease in mitochondrial flux retrogradely, but
knockdown of Nox reduces flux in both directions. C, Velocity is reduced in both
direcitions by down-regulation of Nox, but is reduced only in the retrograde direction
by down-regulation of Duox Number of larvae is shown on bars. Error bars indicate
mean ± SEM. Significance is determined by one-way ANOVA with Bonferroni’s
post-test. *p<0.05, **p < 0.01, and ***p < 0.001.
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Figure 3.7. Endogenous ROS affect mitochondrial duty cycle, run length, and
the percentage of moving mitochondria in vivo. A, Knockdown of Nox gives a
reduction in duty cycle with an increase of pause time and a decrease of moving time
in both directions. Knockdown of Duox decreases retrograde duty cycle and increases
pause time in anterograde direction. B, Run length is reduced by knockdown of Duox
or Nox in both directions. C, Knockdown of Duox shows a decrease of the percentage
of retrograde moving mitochondria. Knockdown of Nox shows an increase of the
percentage of paused mitochondria and a decrease of the percentage of anterograde
moving mitochondria. D, Mitochondrial density is comparable to control with
knockdown of Duox or Nox. Number of larvae is shown on bars. Error bars indicate
mean ± SEM. Significance is determined by one-way ANOVA with Bonferroni’s
post-test. *p<0.05, **p < 0.01, and ***p < 0.001.
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3.5

Mitochondrial fission-fusion balance and inner membrane potential are
both diminished by ROS treatment

3.5.1

Mitochondrial length is reduced under oxidative stress conditions

Different elements of the mitochondrial life cycle including mitochondrial length,
membrane potential, transport, and mitophagy are highly interrelated. For example,
mutation of mitochondrial fusion protein, mitofusin 2, both induces mitochondrial
fragmentation and reduces mitochondrial transport (Verstreken et al., 2005; Baloh et
al., 2007; Misko et al., 2010; Misko et al., 2012).
To determine whether disrupted mitochondrial transport caused by ROS is
accompanied by changes in fission-fusion steady state, mitochondrial length was
examined after H2O2 treatment for 1 hr. After treatment, mitochondrial shapes became
more rounded and length was reduced (Fig. 3.8A, B), indicating that excess ROS
affect the mitochondrial fission-fusion steady state by reducing mitochondrial length.
In addition, overexpression of SOD1 or SOD2 fully rescued the reduced
mitochondrial length (Fig. 3.8A, B), further confirming that these morphological
defects are produced by oxidative stress.

3.5.2

Mitochondrial membrane potential is reduced under oxidative stress
conditions

Mitochondrial membrane potential and mitochondrial transport may be correlated
(Miller and Sheetz, 2004; Saxton and Hollenbeck, 2012). Thus, I also examined
whether ROS-induced inhibition of mitochondrial transport was accompanied by
diminished membrane potential. To test this, mitochondria were stained with TMRM
and mitochondrial membrane potential was expressed as the intensity ratio of
mitochondrial and cytosolic TMRM fluorescence.
Under oxidative stress conditions, mitochondrial membrane potential was reduced,
indicating that the mitochondrial metabolic state is disrupted (Fig. 3.8A, C). However,
SOD1 or SOD2 overexpression did not rescue the diminished mitochondrial
membrane potential caused by ROS (Fig. 3.8A, C), suggesting that SOD
overexpression is not sufficient to rescue these defects. It is possible that other ROS
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scavengers, including glutathione peroxidase or catalase, might be required to restore
the normal metabolic state. Altogether, these data indicate that oxidative stress
produces imbalances in mitochondrial fission-fusion and metabolic state, and suggest
that mitochondrial transport, fission-fusion, and membrane potential are closely
interrelated in the response to ROS.
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Figure 3.8. Mitochondrial length and membrane potential are reduced in
response to ROS. A, Representative images of mitochondrial length and membrane
potential. Mitochondrial lengths are measured using mitoGFP signals and
mitochondrial membrane potential is measured using TMRM staining by the intensity
ratio of mitochondrial fluorescence and cytosolic fluorescence. Scale bars indicate 10
µm. B, Quantitative results of mitochondrial length. ROS treatment shows a decrease
of mitochondrial length, which is rescued by SOD1 or SOD2 overexpression. C,
Quantitative results of mitochondrial membrane potential. Mitochondrial membrane
potential is reduced under oxidative stress conditions. SOD1 or SOD2 overexpression
does not rescue these defects. Number of cells is shown on bars. Error bars indicate
mean ± SEM. Significance is determined by one-way ANOVA with Bonferroni’s
post-test. *p<0.05, and ***p < 0.001.
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3.6

3.6.1

ROS-induced defects of mitochondrial transport are caused by Ca2+ levels
ROS elevate intracellular Ca2+ levels

Mitochondrial transport is inhibited by Ca2+ levels. Mitochondria have Miro
proteins that contain Ca2+ binding EF-domain. When Ca2+ levels increase, Ca2+ binds
the EF-domain on Miro and mitochondrial transport is inhibited (Macaskill et al.,
2009; Wang and Schwarz, 2009; Chen and Sheng, 2013). In addition, it has been
shown that Ca2+ and redox signaling have significant interactions. ROS could
stimulate Ca2+ influx via different Ca2+ channels including voltage-dependent Ca2+
channels or channels involved in receptor-induced Ca2+ signals (Hidalgo and Donoso,
2008; Gleichmann and Mattson, 2011; Görlach et al., 2015). Thus, the defects of
mitochondrial transport caused by oxidative stress might be regulated by elevated
Ca2+ levels.
To determine whether the defects in mitochondrial transport in response to ROS
are related to intracellular Ca2+ levels, Ca2+ levels were measured using the
genetically-encoded calcium indicator GCaMP6 which I expressed in motor neurons
using the D42-Gal4 driver (Chen et al., 2013). After 1 hr H2O2 treatment, cells
showed about 50% higher GCaMP6 intensity compared to controls (Fig. 3.9),
indicating that ROS do indeed induce increased intracellular Ca2+ levels. I also treated
cells for a longer period with ROS and found no further increase in GCaMP intensity,
consistent with the result that longer ROS treatment did not produce further reduced
mitochondrial transport (Fig. 3.1C, above).

3.6.2

Elevated Ca2+ levels inhibit mitochondrial transport specifically

While Ca2+ has been shown to inhibit mitochondrial transport in different systems
(Macaskill et al., 2009; Wang and Schwarz, 2009; Chen and Sheng, 2013), whether
Ca2+ inhibits mitochondrial transport in our system is still unknown. I first artificially
induced Ca2+ levels dramatically by

treating cells with the Ca2+ ionophore,

ionomycin (Fig. 3.9A, B), and examined both mitochondrial transport and DCV
transport (Fig. 3.10A). Notably, this treatment reduced transport of mitochondria only
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(Fig. 3.10B). Compared to controls, the velocity of DCV transport in ionomycintreated cells did not show a significant difference (Fig. 3.10C).
Although mitochondrial transport was reduced in ionomycin-treated cells, Ca2+
levels were much higher than physiological or ROS-treated levels. To confirm that
the reduction did not require a dramatic increase of Ca2+ levels, I treated cells with
thapsigargin, an ER Ca2+ ATPase inhibitor that increases only intracellular Ca2+
levels, to mimic Ca2+ levels under oxidative stress (Fig. 3.9A, B). Under these
conditions, the percentage of moving mitochondria was reduced to a similar level to
that seen in H2O2-treated cells (Fig. 3.1, 3.10D, E). In addition, the velocity of DCV
transport was similar to controls (Fig. 3.10D, F), further confirming that elevated Ca2+
levels reduced mitochondrial transport specifically.

3.6.3

ROS-induced defects of mitochondrial transport is mediated by Ca2+ levels

The results reported in sections 3.6.1 and 3.6.2 indicate that ROS increase
intracellular Ca2+, and that artificially increased Ca2+ levels reduce mitochondrial
transport, supporting the hypothesis that ROS produce defects of mitochondrial
transport through the elevation of Ca2+ levels. To test further the hypothesis, the
ROS-induced increase in Ca2+ levels was stymied by incubating cells in Ca2+-free
medium containing EGTA. Under these conditions, I examined whether ROSinduced defects of mitochondrial transport were rescued.
Before examining transport, I first confirmed that EGTA treatment did reduce Ca2+
levels, using the GCaMP6 indicator (Fig. 3.11A, B). EGTA treatment alone did not
decrease intracellular Ca2+ levels, but it rescued the ROS-induced Ca2+ levels to
physiological levels (Fig. 3.11A, B). Next, I examined mitochondrial transport under
these conditions. Under ROS treatment with Ca2+ levels held to control levels, the
percentage of moving mitochondria was similar to controls (Fig. 3.11C, D). In
addition, the ROS-reduced percentage of moving mitochondria was partially rescued,
indicating that ROS-induced defects of mitochondrial transport are mediated in large
part by the elevation of Ca2+ levels.
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3.6.4

Ca2+ homeostasis is required for mitochondrial transport

Since EGTA treatment, rescuing Ca2+ to physiological levels, rescued ROSinduced defects of mitochondrial transport, I wondered whether further reduction of
Ca2+ levels could increase mitochondrial transport. To examine this, cells were
treated with both EGTA and BAPTA-AM, a Ca2+ chelator that can cross the cell
membrane, to further reduce intracellular Ca2+ levels (Fig. 3.11E, F). First, I showed
that cells incubated with H2O2, EGTA, and BAPTA-AM also showed reduced Ca2+
levels compared to controls (Fig. 3.11E, F), indicating that combined intracellular and
extracellular Ca2+ chelation indeed reduces Ca2+ levels lower than physiological
levels.
Surprisingly, cells with Ca2+ levels lower than physiological levels also showed
unexpected defects in mitochondrial transport. The percentage of moving
mitochondria was reduced under these conditions (Fig. 3.11G, H), indicating that
lower Ca2+ levels also inhibit mitochondrial transport.
Altogether, these data suggest that Ca2+ homeostasis is required for mitochondrial
transport, and that modulation of Ca2+ levels mediates the effect of ROS on
mitochondria.

3.6.5

Ca2+ homeostasis is required for mitochondrial transport

Mitochondrial fission-fusion steady state has been shown to correlate to
mitochondrial transport. Disruption of the fission-fusion steady state by mutation of
mitochondrial fusion protein, Mitofusin, produces mitochondrial fragment and
reduced mitochondrial movement (Verstreken et al., 2005; Baloh et al., 2007; Misko
et al., 2010; Misko et al., 2012). I have shown that oxidative stress reduced both
mitochondrial transport and length (Fig. 3.8A, B). To examine whether the Ca2+induced defects of mitochondrial transport are also related to mitochondrial length
control, I measured the mitochondrial length under the conditions described in section
3.6.4.
I found that the mitochondrial length reduction caused by oxidative stress was
rescued by EGTA treatment but was not rescued by combined BAPTA-AM and
EGTA treatment (Fig. 3.12), which was consistent with the transport data (Fig. 3.11D,
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H). These results indicate that either higher or lower Ca2+ levels affect mitochondrial
length. All together, these data indicate that Ca2+ homeostasis is important for both
mitochondrial transport and mitochondrial fission-fusion steady state.
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Figure 3.9. Elevated Ca2+ levels are induced by H2O2. A, Representative Ca2+
imaging with H2O2, thapsgargin, or ionomycin treatment are measured by the
intensity of GCaMP6 indicator. Scale bars indicate 10 µm. B, Quantitative results
from (A). H2O2 or thapsgargin treatment produces an increase of Ca2+ levels of
similar extent. Ionomycin treatment produces a large increase compared to controls.
Number of cells is shown on bars. Each plate contains at least 5 cells. Error bars
indicate mean ± SEM. Significance is determined by one-way ANOVA with
Bonferroni’s post-test. **p < 0.01, and ***p < 0.001.
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Figure 3.10. Elevated Ca2+ levels inhibit mitochondrial transport. A,
Representative kymographs of axonal transport of mitochondria or DCVs under
ionomycin treatment. Anterograde transport is toward the right; retrograde transport
is toward the left. B, The percentage of moving mitochondria is dramatically reduced
by ionomycin treatment. C, Velocity of DCV transport is not affected by ionomycin.
D, Representative kymographs of axonal transport of mitochondria or DCVs with
thapsigargin treatment. E, The percentage of moving mitochondria is reduced by
thapsigargin treatment, but the effect is not as large as ionomycin treatment. F,
Velocity of DCV transport is not affected by thapsigargin. Number of cells is shown
on bars. Error bars indicate mean ± SEM. Significance is determined by paired
Student’s t-test. ***p < 0.001.
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Figure 3.11. Ca2+ homeostasis is required for normal mitochondrial transport. A,
Representative Ca2+ imaging with H2O2 or EGTA treatment are measured by the
intensity of GCaMP6 indicator. Scale bars indicate 10 µm. B, Quantitative results
from (A). Elevated Ca2+ levels induced by H2O2 are rescued by EGTA treatment.
EGTA alone does not affect intracellular Ca2+ levels. C, Representative kymographs
of mitochondrial transport under H2O2 or EGTA treatment. Anterograde transport is
toward the right; retrograde transport is toward the left. D, The reduced percentage of
moving mitochondria by H2O2 is partially rescued by EGTA. EGTA alone does not
affect mitochondrial transport. E, Representative Ca2+ imaging with H2O2 or
EGTA/BAPTA treatment are measured by the intensity of GCaMP6 indicator. Scale
bars indicate 10 µm. F, Quantitative results from (E). Ca2+ levels are increased by
H2O2 but reduced with EGTA/BAPTA treatment. G, Representative kymographs of
mitochondrial transport with H2O2 or EGTA/BAPTA treatment. Anterograde
transport is toward the right; retrograde transport is toward the left. H,
EGTA/BAPTA treatment produces a decrease of mitochondrial transport. The
reduced percentage of moving mitochondria by H2O2 is further reduced by
EGTA/BAPTA treatment. Error bars indicate mean ± SEM. Number of cells is shown
on bars. Significance is determined by one-way ANOVA with Bonferroni’s post-test.
*p<0.05, **p < 0.01, and ***p < 0.001.
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Figure 3.12. Ca2+ homeostasis is required for normal mitochondrial morphology.
A, Representative images of mitochondrial length measured using the mitoGFP signal.
Scale bars indicate 10 µm. B, H2O2 and/or EGTA/BAPTA reduce mitochondrial
length, which is consistent with the results of mitochondrial transport (Fig. 3.11D, H).
Error bars indicate mean ± SEM. Number of cells is shown on bars. Significance is
determined by one-way ANOVA with Bonferroni’s post-test. **p < 0.01, and ***p <
0.001, compared to the control group.
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3.7

The JNK pathway plays a role in the regulation of mitochondrial transport
in axons by oxidative stress

It seems clear so far that the effects of ROS exposure on mitochondrial transport
are probably not due simply to generalized oxidative damage, but probably involve an
imbalance of normal ROS-based signaling. To investigate this further, I examined the
JNK pathway, which is activated under oxidative stress conditions (Shen and Liu,
2006; Son et al., 2013) and involved in regulating axonal transport (Morfini et al.,
2006; Morfini et al., 2009). Previous studies have shown that activated JNK pathway
reduces axonal transport in squid axoplasm via the phosphorylation of kinesin heavy
chain (Morfini et al., 2006). Thus, I hypothesized that ROS induced defects of
mitochondrial transport involve the activation of the JNK pathway.

3.7.1

Mitochondrial transport is not affected by JNK signaling in vitro

To test this hypothesis, I activated the JNK pathway by overexpressing HepB2
(JNK kinase in Drosophila), or down-regulated it by RNAi knockdown of Bsk (JNK
in Drosophila). I expected that mitochondrial transport would increase with the
down-regulation of the JNK pathway and decrease with the activation of the JNK
pathway.
However, when I examined the percentage of moving vs. persistently stationary
mitochondria in Drosophila neurons in vitro, I did not find significant differences
between control and JNK activation/down-regulation under basal conditions. In
addition, under oxidative stress, the percentage of moving mitochondria was reduced
in both overexpression and knockdown animals (Fig. 3.13), suggesting that JNK
signaling is not involved in the regulation of mitochondrial transport in response to
ROS in vitro.

3.7.2

The JNK signaling pathway plays a role in the regulation of mitochondrial
transport under oxidative stress in vivo

Previous studies have shown that the JNK pathway affected axonal transport
mainly in anterograde direction (Morfini et al., 2006; Morfini et al., 2009). It is
possible that the percentage of moving mitochondria in vitro is not high enough to
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reveal directional defects. To determine more accurately whether the JNK pathway
affected mitochondrial transport only in one direction, I examined more detailed
parameters in vivo.
First, I examined the gross transport indicator, flux. In the anterograde direction,
flux was reduced by JNK activation. In addition, under oxidative stress conditions,
flux was not further reduced by JNK activation (Fig. 3.14A, B), implying that the
JNK pathway is downstream of the effects of oxidative stress on anterograde
mitochondrial flux. Furthermore, the ROS-induced defects in anterograde flux were
partially rescued by JNK knockdown (Fig. 3.14A, B), also suggesting that the JNK
pathway plays a role in mediating the inhibition of mitochondrial anterograde
transport by oxidative stress. To analyze which parameters resulted in the reduced
flux, velocity, duty cycle, run length, and the percentage of mitochondria were
examined. Similar to the flux results, activation of the JNK pathway reduced
mitochondrial velocity (Fig. 3.14A, C), and down-regulation of JNK partially rescued
the reduced velocity caused by ROS treatment in the anterograde direction (Fig.
3.14A, C), indicating that the velocity is one of the factors contributing to the
difference in flux.
However, for retrograde movement, either activation or down-regulation of the
JNK pathway produced a decrease of mitochondrial flux and velocity under oxidative
stress conditions (Fig. 3.14A-C), suggesting that other mechanisms might be
responsible for the regulation of the effects of oxidative stress on retrograde
mitochondrial transport.

Thus, although the regulatory systems are directionally

differentiated, optimal levels of activity in the JNK pathway are important for
mitochondrial transport in both directions. Other parameters of mitochondrial motility
such as duty cycles, run length, and the percentage of moving mitochondria were only
modestly affected by either overexpression or knockdown of the JNK pathway (Fig.
3.15), indicating that JNK signaling mediates mitochondrial flux in response to ROS
mainly via effects on velocity.
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3.7.3

Activation of the JNK pathway shows a decrease of mitochondrial density

In addition to transport parameters, mitochondrial density was examined under
these conditions (Fig. 3.16). Surprisingly, activation of the JNK pathway produced a
decrease in axonal mitochondrial density (Fig. 3.16). This reduced density did not
further decrease under oxidative stress conditions (Fig. 3.16), suggesting that the
activation of the JNK pathway might reduce mitochondrial biogenesis and/or increase
mitochondrial degradation. In addition, the reduced density also implicates another
component of the mitochondrial life cycle that could contribute to the difference in
the flux.
In sum, these results demonstrated that the JNK pathway, activated by oxidative
stress, plays a role in the regulation of mitochondrial transport in the anterograde
direction, consistent with the role of JNK in the regulation of anterograde-specific
axonal transport. In addition to mitochondrial transport, the JNK pathway also plays a
role in the regulation of mitochondrial density, suggesting the important role of JNK
signaling on mitochondrial quality control.

67

Figure 3.13. The percentage of moving mitochondria is not affected by the JNK
pathway under oxidative stress conditions in vitro. A, Representative kymographs
of mitochondrial transport with overexpression of JNK kinase (HepB2) or knockdown
of JNK (Bsk RNAi) in response to H2O2. Anterograde transport is toward the right;
retrograde transport is toward the left. B, The percentage of moving mitochondria is
reduced with H2O2 treatment. Either overexpression of JNK kinase (HepB2) or
knockdown of JNK (Bsk RNAi) does not rescue the defects. Number of plates is
shown on bars. Each plate contains at least 5 cells. Error bars indicate mean ± SEM.
Significance is determined by one-way ANOVA with Bonferroni’s post-test. *p<0.05,
**p < 0.01, and ***p < 0.001, compared to the control group.
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Figure 3.14. The JNK pathway plays a role in the regulation of mitochondrial
transport in vivo. A, Representative kymographs of mitochondrial transport with
overexpression of JNK kinase (HepB2) or knockdown of JNK (Bsk RNAi) in response
to paraquat. Anterograde transport is toward the right; retrograde transport is toward
the left. B, Paraquat and/or overexpression of HepB2 produce a decrease in
mitochondrial flux anterogradly. Knockdown of Bsk partially rescues the effect of
paraquat. Both overexpression of HepB2 and knockdown of Bsk reduce retrograde
flux. C, Anterograde velocity is reduced by paraquat or overexpression of HepB2, and
knockdown of Bsk partially rescues the effect of paraquat. Retrograde velocity is
reduced in both overexpression of HepB2 and knockdown of Bsk. Number of larvae is
shown on bars. Error bars indicate mean ± SEM. Significance is determined by oneway ANOVA with Bonferroni’s post-test. *p<0.05, **p < 0.01, and ***p < 0.001.
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Figure 3.15. Mitochondrial duty cycle, run length, and percentage of moving are
not affected by the JNK pathway in vivo. A, Paraquat treatment shows slightly
reduction in retrograde duty cycle with a decrease of moving time; Knockdown of
Bsk in response to paraquat shows a slightly increase of pause and a decrease of
moving time. B, Retrograde run length is modestly reduced by paraquat treatment.
Either overexpression of HepB2 of knockdown of Bsk does not show significant
difference compared to controls. C, Paraquat treatment shows an increase of the
percentage of stationary mitochondria, while either overexpression of HepB2 of
knockdown of Bsk does not show significant difference. Number of larvae is shown
on bars. Error bars indicate mean ± SEM. Significance is determined by one-way
ANOVA with Bonferroni’s post-test. *p<0.05 and **p < 0.01.
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Figure 3.16. Activation of the JNK pathway shows a decrease of mitochondrial
density. A, Representative binary images of mitochondrial density with
overexpression of HepB2 or knockdown of Bsk in response to paraquat treatment. B,
Overexpression of HepB2 shows reduced integrated mitochondrial density compared
to the control. Number of larvae is shown on bars. Error bars indicate mean ± SEM.
Significance is determined by one-way ANOVA with Bonferroni’s post-test. **p <
0.01 and ***p < 0.001.
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3.8

Activation or down-regulation of the JNK pathway does not affect
intracellular Ca2+ levels

Previous results provide evidence that ROS-induced defects of mitochondrial
transport are mediated by Ca2+ and the JNK pathway (Section 3.6 and 3.7, above).
However, it is not clear how Ca2+ and the JNK pathway might interact in the ROS
regulation of mitochondrial transport. To determine whether the JNK pathway is
upstream of Ca2+ signaling, I examined intracellular Ca2+ levels in primary neurons
expressing GCaMP6 with either genetic activation or down-regulation of the JNK
pathway in motor neurons.
Similar to previous results, these neurons showed about 50% higher GCaMP6
intensity compared to controls after H2O2 treatment (Fig. 3.9 and 3.17). However,
neither activation nor down-regulation of the JNK pathway affects intracellular Ca2+
levels (Fig. 3.17B), indicating that the JNK pathway is not upstream of the Ca2+
signaling. This suggests that the defects of mitochondrial transport caused by ROSinduced Ca2+ levels are not mediated by the JNK pathway, and also raises the
possibility that Ca2+ and JNK signaling regulate mitochondrial transport in parallel.
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Figure 3.17 Activation or down-regulation of the JNK pathway does not affect
intracellular Ca2+ levels. A, Representative Ca2+ imaging with overexpression of
HepB2 or down-regulation of Bsk; Ca2+ is measured by the intensity of GCaMP6
fluorescence. Scale bars indicate 10 µm. B, Quantitative results from (A). H2O2
treatment produces an increase of Ca2+ levels, but neither overexpression of HepB2
nor down-regulation of Bsk produces a significant difference in the result. Number of
plates is shown on bars. Each plate contains at least 5 cells. Error bars indicate mean
± SEM. Significance is determined by one-way ANOVA with Bonferroni’s post-test.
**p < 0.01.
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CHAPTER 4. DISCUSSION

Although excess ROS produce varied damage to macromolecules, organelles and
cells (Brookes et al., 2004; Court and Coleman, 2012), they are probably more in
their important roles as signaling molecules at physiological levels (Lambeth and
Neish, 2014; Nayernia et al., 2014). Mitochondria are the major source of ROS
(Brookes et al., 2004; Bhat et al., 2015; Genova and Lenaz, 2015) and also are
damaged by them: since ROS have been shown to affect mitochondrial transport,
fission-fusion, and mitophagy in vitro (Jendrach et al., 2008; Fan et al., 2010; Fang et
al., 2012; Frank et al., 2012), it is important to elucidate the underlying mechanisms
linking these effects. In this study, I have focused on the relationship between ROS
and mitochondrial transport, and have demonstrated fundamental mechanistic
connections between these two. I find that: 1) ROS specifically reduce mitochondrial
transport both in vitro and in vivo, and produce a decrease of mitochondrial length
and membrane potential; 2) In addition to excess ROS, the reduction of physiological
ROS levels by knockdown of the Nox family also induces defects in mitochondrial
transport. 3) Excess ROS disturb neuronal Ca2+ homeostasis, increasing Ca2+ levels,
which in turn inhibit mitochondrial transport and reduce mitochondrial length; 4)
ROS-induced defects of mitochondrial transport are mediated by a signaling pathway.
The JNK pathway in particular plays a role in the regulation of anterograde transport
in the presence of excess ROS.

4.1

Mitochondrial transport is preferentially affected by ROS

Mitochondrial axonal transport is reduced in the presence of excess ROS both in
vitro and in vivo, primarily via reduced organelle flux and velocity (Fig. 3.1 – 3.3).
More important, ROS preferentially affect mitochondria, since the transport of DCVs
is barely affected under oxidative stress conditions (Fig. 3.4 and 3.5).

This is
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consistent with a previous in vitro study that though mitochondria and Golgi-derived
vesicles show reduced mobility by ROS, mitochondrial transport is preferentially
affected (Fang et al., 2012). Based on these studies, I propose that among the axonal
transport cargoes, mitochondria are a prime target of ROS.
What possible mechanism could explain the specific sensitivity of mitochondrial
transport to ROS? Unlike other axonal vesicles and organelles, mitochondria are
linked to kinesin motor proteins via a complex of a mitochondrial Rho GTPase, Miro,
and the adapter protein, Milton. When the intracellular Ca2+ levels increase, Ca2+
binds to the two EF-domains of Miro, causing a conformational change that disrupts
the ability of kinesin to move the mitochondria but, interestingly, inhibiting both
directions of mitochondrial transport (Macaskill et al., 2009; Wang and Schwarz,
2009; Chen and Sheng, 2013). This regulation by Ca2+ is a major difference in the
axonal transport of mitochondria versus other organelles, and prompted one of my
areas of experimentation.
The JNK pathway might also affect mitochondrial transport more specifically.
While several studies suggest that the JNK pathway affects general axonal transport
via phosphorylation of kinesin or superior cervical ganglion 10 (SCG10), a
microtubule binding protein in axons (Morfini et al., 2006; Shin et al., 2012), other
studies suggest that there is a regulatory difference in transport between mitochondria
and other cargoes. For example, mutants in APLIP1, the Drosophila homologue of a
JNK-interacting protein (JIP), reduce general transport of cargoes in both directions,
but reduce mitochondrial transport only in the retrograde direction, suggesting a
unique regulatory feature of mitochondrial transport (Horiuchi et al., 2005). In
addition, the alpha subunit of the heterotrimeric G protein G12 (Gα12) has been
shown to stimulate JNK activity (Nagao et al., 1999); this is notable because Gα12 is
targeted to mitochondria and itself affects mitochondrial motility (Andreeva et al.,
2008). These studies suggest the possibility that the JNK pathway has some specific
effects on axonal transport of mitochondria.
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4.2

ROS homeostasis is required for mitochondrial transport

In addition to elucidating the effects of excess ROS on mitochondrial transport, I
have also provided evidence that ROS levels reduced below physiological conditions
by knockdown of the Nox family also impaired mitochondrial transport (Fig. 3.6 and
3.7). Interestingly, though knockdown of Nox and Duox reduces mitochondrial
transport, the detailed motility phenotypes are different. Knockdown of Nox produces
the general reduction in different parameters of transport in both directions, whereas
knockdown of Duox affects general retrograde transport but only anterograde run
length (Fig. 3.6 and 3.7). This suggests unique different regulatory features of
mitochondrial transport. More specifically, Nox and Duox are both required for
retrograde transport. However, Nox might play more important roles in the
anterograde transport, since knockdown of Nox affects all parameters of anterograde
transport. Knockdown of Duox only affect run length, suggesting that mitochondria
spend more runs to reach the destination. Thus, it is possible that the role of Duox in
the anterograde transport is to maintain efficient, continuous movement. It has been
shown that myosin motors compete with microtubule-based motors and halt
mitochondrial movement (Pathak et al., 2010). Whether Duox prevents competition
between myosin and microtubule-based motors remains for further investigation.
What could explain the effects of Nox and Duox downregulation on mitochondrial
transport? Since their main function is ROS production, knockdown of these enzymes
reduces ROS levels below physiological levels. Under normal physiological
conditions, ROS serve as important signaling molecules and regulate numerous
cellular functions (Lambeth and Neish, 2014; Nayernia et al., 2014) (Section 1.2.2.2,
above). Thus, it should not be surprising that knockdown of Nox and Duox impairs
mitochondrial transport. Are there any signaling pathways or mechanisms that can be
related to the impairment of mitochondrial transport by low ROS? One candidate is
the PI3K/Akt/GSK3β pathway. This pathway has been shown to be activated by Noxreleased ROS (Nakanishi et al., 2014) and to stimulate mitochondrial transport (Chen
et al., 2007). Thus, knockdown of Nox family, which reduces ROS levels, may be
impairing

mitochondrial

PI3K/Akt/GSK3β pathway.
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inactivation

of

76
4.3

The ROS-induced effects on mitochondrial transport is mediated via
changes of Ca2+ levels

As mentioned above (Section 1.1.4.1 and 4.1), cytosolic Ca2+ regulates
mitochondrial transport. Here I have shown that excess ROS do increase Ca2+ levels
(Fig. 3.9) and that Ca2+ chelation by EGTA rescues the defects of mitochondrial
transport (Fig. 3.11A - D), consistent with Ca2+ inhibition of mitochondrial transport
(Macaskill et al., 2009; Wang and Schwarz, 2009; Chen and Sheng, 2013).
It is notable that H2O2-induced high Ca2+ levels are rescued to physiological levels
by the extracellular Ca2+ chelator EGTA (Fig. 3.11A and B), suggesting that the
ROS-induced Ca2+ increase is caused by the Ca2+ influx from the extracellular
environment. A likely explanation involves several Ca2+ channels on the plasma
membrane that are regulated by redox balance (Görlach et al., 2015). For example,
H2O2 treatment has been shown to induce Ca2+ influx through L-type or T-type
voltage-dependent Ca2+ channels (VDCC) (Hudasek et al., 2004; Tabet et al., 2004)
(Section 1.2.4.1). In addition to VDCC, ROS are known to stimulate Ca2+ influx
through channels involved in receptor-induced Ca2+ signals such as transient receptor
potential (TRP) channels and store-operated Ca2+ channels (SOC) mediated by Orai
channel proteins (Hara et al., 2002; Grupe et al., 2010) (Section 1.2.4.1). Thus, I
propose that elevated Ca2+ levels are induced by ROS through stimulating one or
more Ca2+ channels on the plasma membrane.
While most studies have focused on the effects of elevated Ca2+ levels on
mitochondrial transport (Macaskill et al., 2009; Wang and Schwarz, 2009; Chen and
Sheng, 2013; Nguyen et al., 2014; Stephen et al., 2015), I found that experimentally
decreased intracellular Ca2+ levels also produce a decrease of mitochondrial transport
(Fig. 3.11E - H), indicating that normal Ca2+ homeostasis is important for
mitochondrial transport. This might explain a previous study showing that the defects
of mitochondrial transport induced by MPP+ are rescued by thio-antioxidant Nacetylcystein (NAC; precursor of glutathione), whereas they are not rescued by a high
concentration of EGTA (2.5 mM). The latter probably reduced Ca2+ levels below
physiological conditions (Kim-Han et al., 2011).
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4.4

The ROS-induced defects of mitochondrial transport is mediated by the
signaling pathway

Although Ca2+ levels regulate mitochondrial transport, I found that the defects of
mitochondrial transport was not fully rescued by Ca2+ chelation (Fig. 3.11A - D),
suggesting that other factors might be involved in ROS regulation of mitochondrial
transport. Indeed, several signaling pathways have been shown to regulate axonal
transport. Axonal mitochondria are recruited in response to Nerve Growth Factor
(NGF), and this recruitment is regulated in part via the phosphoinositide 3-kinase
(PI3K) (Chada and Hollenbeck, 2004). Glycogen synthase kinase 3 (GSK3) can
phosphorylate kinesin light chain (Klc) to inhibit axonal transport, whereas activation
of Akt, which inhibits GSK3β, stimulates axonal mitochondrial transport (Morfini et
al., 2002; Chen et al., 2007). In addition, activation of the JNK pathway
phosphorylates kinesin heavy chain (Khc), reducing the interaction between kinesins
and microtubules and thus inhibiting anterograde axonal transport (Morfini et al.,
2006) (Section 1.1.4.2).
Here I have shown that activation of the JNK pathway reduces anterograde
mitochondrial transport, and that ROS-induced defects are rescued by knockdown of
the JNK pathway (Fig. 3.14). This anterograde direction-specific regulation might be
caused by the phosphorylation of kinesin by JNK (Morfini et al., 2006). In the
retrograde direction, knockdown of the JNK pathway decreases mitochondrial
transport (Fig. 3.14). It has been shown that JIPs are required for the stress-induced
JNK activation (Yasuda et al., 1999; Whitmarsh et al., 2001; Taru et al., 2002), and
the mutation of the Drosophila JIP homologue reduces mitochondrial transport only
in the retrograde direction (Horiuchi et al., 2005). Thus, disruption of the JNK
pathway either by knockdown of JNK or by mutation of a Drosophila JIP homologue
is suggested to produce retrograde-specific defects of mitochondrial transport
although the mechanism remains unknown.
Although I found that the JNK pathway plays a role in the regulation of ROSinduced defects of mitochondrial transport, I have not excluded other signaling
pathways from the regulation. Since ROS activate the PI3/Akt/GSK3β pathway
(Clerkin et al., 2008; Zhang et al., 2016), and activation of the PI3/Akt/GSK3β
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pathway stimulates mitochondrial transport (Chen et al., 2007), I initially did not
consider this pathway as a candidate. However, two recent studies have provided
evidence that overexpression of GSK3β promotes mitochondrial transport (LlorensMartín et al., 2011; Ogawa et al., 2016), raising the possibility that ROS might also
inhibit mitochondrial transport via the PI3/Akt/GSK3β pathway.
In addition to the effects on mitochondrial transport, activation of the JNK pathway
reduces mitochondrial density (Fig. 8). This density reduction might involve
upregulation of the mitophagic process. JNK has been shown to increase the
expression of the mitophagy marker Bcl-2 E1B 19-KDa interacting protein 3 (BNIP3)
in stressed cardiomyocytes (Chaanine et al., 2012), and to stabilize PINK1 on the
mitochondrial outer membrane and subsequently activate mitophagy in stressed
neuroblastoma cells (Park et al., 2016). These two results suggest that the reduced
density might result from increased mitophagy produced by activated by JNK.

4.5

How might Ca2+ and the JNK pathway interact in the ROS regulation of
mitochondrial transport?

Several studies have shown that elevated intracellular Ca2+ levels activate the JNK
pathway, and subsequently induce apoptosis or neurodegeneration (Kim and Sharma,
2004; Sato et al., 2015; Zhang et al., 2015). However, it is possible that the JNK
pathway is not simply downstream of Ca2+ signaling in the ROS regulation of
mitochondrial transport. ROS could increase Ca2+ influx from extracellular
environment by activating Ca2+ channels on the plasma membrane (Hara et al., 2002;
Hudasek et al., 2004; Tabet et al., 2004; Grupe et al., 2010), and activate the JNK
pathway via the mediation of ASK1 (Tobiume et al., 2001; Shen and Liu, 2006; Son
et al., 2013), suggesting parallel, independent pathways of ROS-activated Ca2+ influx
and JNK signaling. Activation or down-regulation of JNK signaling does not affect
Ca2+ levels (Fig. 3.17), supporting the parallel hypothesis. In addition, Ca2+ inhibits
mitochondrial transport in both directions (Macaskill et al., 2009; Wang and Schwarz,
2009; Chen and Sheng, 2013), but activation of the JNK pathway inhibits
mitochondrial transport in anterograde direction (Fig. 3.14). Since Ca2+ influx and the
JNK pathway are likely activated by ROS via different mechanisms, and produce
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different effects on mitochondrial transport, it is likely that they regulate
mitochondrial transport in parallel.

4.6

Mitochondrial fission-fusion, metabolic state, and transport are
interrelated in response to ROS

In addition to elucidating the mechanistic connection between ROS and
mitochondrial transport, I have provided evidence that mitochondrial quality control
is correlated with transport. I found that excess ROS and abnormal Ca2+ homeostasis
impair mitochondrial transport (Fig. 3.1, 3.2, 3.3, 3.10, and 3.11A - D) and reduce
mitochondrial length (Fig. 3.8A, B and 3.11E - J). Moreover, when mitochondrial
transport is rescued either by SOD overexpression (Fig. 3.1 and 3.2) or by EGTA
treatment (Fig. 3.11C, D), mitochondrial length is also rescued (Fig. 4A, B, and 6I, J).
Previous studies have shown that the mutation of the mitochondrial fusion protein,
Mitofusin, reduces mitochondrial length, impairs mitochondrial transport and
increases Ca2+ levels in axons (Baloh et al., 2007; Misko et al., 2010; Misko et al.,
2012), consistent with our findings. These studies together reinforce the idea that
mitochondrial

fission-fusion

and

transport

are

highly

interrelated.

This

interrelationship between fission-fusion and transport is possibly related to
Miro/Milton complex since Mitofusin can interact with Miro/Milton complex, and the
transport defects produced by knockdown of Miro is similar to the defects caused by
knockout of Mitofusin (Misko et al., 2010).
This study also provides evidence that both mitochondrial membrane potential and
transport are reduced in response to ROS (Fig. 3.1 - 3.3), suggesting an association
between these two. This idea is supported by other studies in neurodegenerative
disease models. For example, in a Drosophila model of Friedreich Ataxia, reduced
frataxin expression produce defects in mitochondrial transport and membrane
potential; PINK1 mutation also reduces both mitochondrial transport and membrane
potential. (Shidara and Hollenbeck, 2010; Devireddy et al., 2015). In addition, in
mammalian primary neurons, cells treated by ATPase blocker oligomycin or by an
uncoupler (FCCP or CCCP), which inhibits mitochondrial electron transport, produce
a decrease in mitochondrial transport (Rintoul et al., 2003; Miller and Sheetz, 2004).
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These studies show that defects in mitochondrial membrane potential are
accompanied with defects in mitochondrial transport, suggesting the interplay
between them.
In conclusion, I have provided evidence that oxidative stress not only affects
mitochondrial morphology and membrane potential, but also reduces mitochondrial
axonal transport both in vitro and in vivo. These defects in mitochondrial transport are
caused by an imbalance of Ca2+ homeostasis and activation of the JNK pathway.
Furthermore, under physiological conditions, ROS homeostasis is important for
mitochondrial transport. Thus, our study establishes the mechanistic links between
ROS and mitochondrial transport, and suggests a possible new and more subtle role
for ROS in the induction of neurodegeneration, which will suggest new strategies to
ameliorate neurodegenerative diseases.
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